先端医療シリーズ17　脳血管障害の最新医療

書籍・雑誌
≪全国送料無料でお届け≫
品切れ

13,619 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

6,810 円(税込)

購入する

商品紹介

研究・臨床ともに新しい時代に入りつつあるといえる脳血管障害治療のトピックスを網羅し、各分野の専門家に紹介していただいた。本書が脳血管障害の研究、治療に携わる方々への指針となれば、編集に携わったものとして幸いである。

目次

  • 先端医療シリーズ17　脳血管障害の最新医療

    ―　目　次　―

    序　章
    第１章　脳血管障害治療の課題と展望
    第２章　脳血管障害のＥＢＭ
    第３章　新しい認識に基づいた脳血管障害の病因と治療
    第４章　脳血管障害の新しい画像診断法
    第５章　脳血管障害の新しい治療法
    第６章　脳動脈瘤
    第７章　モヤモヤ病
    第８章　診断・治療装置と機材の進歩
    第９章　治療薬開発に関する最新情報
    第１０章　各種製品の臨床評価

    　技術資料編

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

序章

P.3 掲載の参考文献
1) Liu J, Solway K, Messing RO, Sharp FR:Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neuorscience 18:7768-7778, 1998
 
2) Kondziolka D, Wechsler L, Goldstein S, et al:Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565-569, 2000
PubMed
3) Chen J, Li Y, Wang L, et al:Therapeutic benefit of intracerebral transplantationof bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189:49-57, 2001
 
P.9 掲載の参考文献
1) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2446, 1997
PubMed
2) Staessen JA, Fagard R, Thijs L, et al:Randomised double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350:757-764, 1997
PubMed
3) Tuomilehto J, Rastenyte D, Birkenhagar WH, et al:Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 340:677-684, 1999
 
4) Messerli FH, Grossman E, Goldbourt U, et al:Are beta-blockers efficacious as first-line therapy for hypertension in the elderly?A systemic review. JAMA 279:1903-1907, 1998
 
5) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (9287):1033-1041, 2001
 
6) Yokota C, Hasegawa Y, Minematsu K, et al:Effect of acetazolamide reactivity on long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 29:640-644, 1998
PubMed
7) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333:1581-1587, 1995
 
8) 小林祥泰:脳卒中急性期患者データベースの構築に関する研究.健康科学総合研究事業平成13年度研究報告書, 2002
 
9) 山口啓二, 堀進悟:脳梗塞超急性期血栓溶解療法の需要.日本救急医学会雑誌 11:533, 2000 (抄録)
 
10) 小林祥泰:全国脳卒中データバンク構築に向けて. 脳卒中 2002, 印刷中
 
11) Gubitz G, Counsell C, Sandercock P, et al:Antico-agulants for acute ischemic stroke(Review). The Cochrane database of systemic reviews. In Cochrane Library, The Cochrane Collaboration, Issue 4, 2000
 
12) TOAST Investigators:Low molecular weight heparinoid, Org 10172(danaparoid), and outcome after acute ischemic stroke. JAMA 279:1265-1272, 1998
PubMed
13) International Stroke Trial Collaborative Group:The International Stroke Trial(IST):arandomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 (9065):1569-1581. 1997
PubMed
14) CAST (Chinese Acute Stroke Trial) Collaborative Group:CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641-1649, 1997
 
15) The Abciximab in Ischemic Stroke Investigators.:Abciximab in acute ischemic stroke:a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 31 (3):601-609, 2000
PubMed
16) Hofmann R, Kerschner K, Steinwender C, et al:Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting:a randomized study. Stroke 33:725-727, 2002
 
17) Terasawa K, Shimada Y, Kita A, et al:Choto-san in the treatment of vascular dementia:a double-blind, placebo-controlled study. Phytomedicine 4:15-22, 1997
 
18) 小林祥泰:脳卒中後の認知障害に対する釣藤散の効果-事象関連電位による検討.嶋田豊:高齢者の脳血管障害の予防と進展防止を目的とした漢方薬による治療法の開発.厚生科学研究費補助金, 長寿科学総合研究事業平成13年度報告書, 18-20, 2002
 
19) 嶋田豊:高齢者の脳血管障害の予防と進展防止を目的とした漢方薬による治療法の開発.厚生科学究費補助金, 長寿科学総合研究事業平成12年度報告書, 7-10, 2001
 
20) 嶋田豊:高齢者の脳血管障害の予防と進展防止を目的とした漢方薬による治療法の開発.厚生科学研究費補助金, 長寿科学総合研究事業平成13年度報告書, 8-13, 2002
 
21) 小林祥泰:脳血管障害の脳循環, 高次機能に対する漢方薬の効果に関する研究.嶋田豊:高齢者の脳血管障害の予防と進展防止を目的とした漢方薬による治療法の開発.厚生科学研究費補助金, 長寿科学総合研究事業平成12年度報告書, 11-12, 2001
 
22) Wang HC, Hsieh LF, Chi WC, et al:Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients. Am J Phys Med Rehabil 81:272-278, 2002
PubMed
23) 本望修, 上出廷治, 端 和夫:神経幹細胞応用の可能性について.Neurological Surgery 29:293-304, 2001
 
24) Chen J, Li Y, Wang L, et al:Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats."Stroke 3):1005-1011, 2001
 
25) Li Y, Chen J, Wang L, et al:Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56:1666-1672, 2001
 
26) Chen J, Sanberg PR, Li Y, et al:Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (11):2682-2688, 2001
PubMed

第1章 脳血管障害治療の課題と展望

P.17 掲載の参考文献
1) Grabowski M, Johansson BB, and Brundin P:Survival of fetal neocortical grafts implanted in brain infarcts of adult rats:the influence of postlesion time and age of donor tissue. Exp Neurol 127:126-36, 1994
PubMed
2) Koide K, Hashitani T, Aihara N, Mabe H, and Nishino H:Improvement of passive avoidance task after grafting of fetal striatal cell suspensions in ischemic striatum in the rat. Restor. Neurol. Neurosci. 5:205-214, 1993
PubMed
3) Borlongan CV, Tajima Y, Trojanowski JQ, Lee VMY, and Sanberg PR:Transplantation of cryopreserved human embryonal carcinoma-derived neurons(NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149:310-321, 1998
 
4) Shigeno T, Mima T, Takakura K, Graham DI, Kato G, Hashimoto Y, and Furukawa S:Amelioration ofdelayed neuronal death in the hippocampus by nerve growth factor. J Neurosci. 11:2914-2919, 1991
 
5) Yoshida H, Date I, Shingo T, Fujiwara K, Miyoshi Y, Furuta T, and Ohmoto T:Evaluation of reaction of primate brain to grafted PC12 cells. Cell Transplant 8:427-30, 1999
PubMed
6) Date I, Ohmoto T, Imaoka T, Ono T, Hammang JP, Francis J, Greco C, and Emerich DF:Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J Neurosurg 8:1006-12, 1996
 
7) Emerich DF, Winn SR, Christenson L, Palmatier MA, Gentile FT, Sanberg PR:A novel approach to neural transplantation in Parkinson's disease:Use of polylmer-encapsulated cell therapy. Neurosci Biobehav Rev 16:437-447, 1992
PubMed
8) Fujiwara K, Date I, Shingo T, Yoshida H, Kobayashi K, Takeuchi A, Tamiya T, and Ohmoto T:Neurotrophic factor secreting cell grafting for cerebral ischemia:preliminary report. Cell Transplant 10:419-22, 2001
PubMed
8) Date I, Shingo T, Ohmoto T, and Emerich DF:Long-term enhanced chromaffm cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells. Exp Neurol 147:10-17, 1997
 
9) Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, Reitmart MA, and Bynum L:Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565-9, 2000
 
10) Meltzer CC, Kondziolka D, DeCesare S, and Jacobs A:Serial 18F-Fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery 49:586-592, 2001
PubMed
11) Nelson PT, Kondziolka D, Wechsler L. Goldstein S, Gebel J, DeCesare S, Elder EM, Zhang PJ, Jacobs A, McGrogan M, Lee VM, and Trojanowski JQ:Clonal human(hNT) neuron for stroke therapy:Neuropathology in a patient 27 months after implantation. Am J Pathol. 160:1201-6, 2002
 
12) Gage FH:Mammalian neural stem cells. Science. 287:1433-1438, 2000
PubMed
12) Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 5:434-8, 1999
PubMed
13) Zhang ZG, Zhang L, Jiang Q, Chopp M:Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90:284-8, 2002
 
14) Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, and Prockop DJ:Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci U S A 95:3908-13, 1998
PubMed
15) Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Oritiz-Gonzalez XR. Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Linsberg A, Low WC, Langaespada DA, and Verfaillie CM:Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;rapid online
 
16) Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, and Low WC:Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemicbrain of rats. Exp Neurol 174:11-20, 2002
 
17) Reynolds BA, and Weiss S:Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 255:1707-10, 1992
 
18) Sinden JD, Rashid-Doubell F, Kershaw TR, Nelson A, Chadwick A, Jat PS, Nobel MD, Hodges H, and Gray JA. Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischemia-lesioned hippocampus. Neuroscience 81:599-608, 1997
 
19) Toda H, Takahashi J, Iwakami N, Kimura T, Hoki S, Mozumi-kitamura K, Ono S, Hashimoto N:Grafting neural stem cells improved the impaired spatial recognition on ischemic rats. Neurosci Lett 316:9-12, 2001
PubMed
20) Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, and Bjorklund A:Site-specific migration and neurona differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 19:5990-6005, 1999
 
21) Shingo T, Sorokan ST, Shimazaki T, and Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21:9733-43, 2001
 
22) Andsberg G, Kokaia Z, Bjorklund A, Lindvall O, and Martinez-Serrano A:Amelioration of ischemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. Eur J Neurosci 10:2026-36, 1998
PubMed
23) Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O:Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA. 99:2344-9 , 2002
 
24) Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M:Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 110:429-441, 2002
PubMed
P.24 掲載の参考文献
1) Strachan T, Read PR:ヒトの分子遺伝学. Medical Science International, Ltd., Tokyo, 1997
 
2) International Human Genome Sequencing Consortium:Initial sequencing and analysis of the human genome. Nature 409:860-921, 2001
PubMed
3) Venter JC, Adams MD, Myers EW, et al:The sequence of the human genome. Science 291:1304-1351, 2001
 
4) 宮田敏行:脳神経外科における的確な遺伝子診断と治療 2. 遺伝子診断の手法.脳神経外科ジャーナル, in press
 
5) Hirakawa M, Tanaka T, Hashimoto Y, et al:JSNP:a database of common gene variations in the Japanese population. Nucleic Acids Res 30:158-162, 2002
PubMed
6) Kissela BM, Sauerbeck L, Woo D, et al:Subarachnoid hemorrhage:a preventable disease with a heritable component. Stroke 33:1321-1326, 2002
PubMed
7) Schievink WI, Schaid DJ, Michels VV, et al:Familial aneurysmal subarachnoid hemorrhage:a community-based study. J Neurosurg 83:426-429, 1995
PubMed
8) Ronkainen A, Hernesniemi J, Puranen M, et al:Familial intracranial aneurysms. Lancet 349:380-384, 1997
PubMed
9) Kojima M, Nagasawa S, Lee YE, et al:Asymptomatic familial cerebral aneurysms. Neurosurgery 43:776-781, 1998
PubMed
10) Onda H, Kasuya H, Yoneyama T, et al:Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet 69:804-819, 2001
PubMed
11) Olson JM, Vongpunsawad S, Kuivaniemi H, et al:Search for intracranial aneurysm susceptibility gene(s) using Finnish families. BMC Med Genet 3:7, 2002
 
12) Brega KE, Seltzer WK, Munro LG, et al:Genotypic variations of type III collagen in patients with cerebral aneurysms. Surg Neurol 46:253-256;discussion 256-257, 1996
 
13) Takenaka K, Sakai H, Yamakawa H, et al:Polymorphism of the endoglin gene in patients With intracranial saccular aneurysms. J Neurosurg 90:935-938, 1999
PubMed
14) Peters DG, Kassam A, St Jean PL, et al:Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 30:2612-2616, 1999
PubMed
15) Gunel M, Lifton RP:Counting strokes. Nat Genet 13:384-385, 1996
PubMed
16) 竹中勝信, 加藤貴之, 村川孝次:脳卒中患者のゲノム解析の現状.高山赤十字病院紀要 24:3-7, 2000
 
17) McAllister KA, Grogg KM, Johnson DW, et al:Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351, 1994
PubMed
18) Johnson DW, Berg JN, Baldwin MA, et al:Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189-195, 1996
PubMed
19) Alberts MJ, Davis JP, Graffagnino C, et al:Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage. Ann Neurol 41:683-686, 1997
PubMed
20) Gunel M, Awad IA, Anson J, et al:Mapping a gene causing cerebral cavernous malformation to 7q11. 2-q21. Proc Natl Acad Sci U S A 92:6620-6624, 1995
PubMed
21) Craig HD, Gunel M, Cepeda O, et al:Multilocus linkage identifies two new loci for a mendelian fom of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25. 2-27. Hum Mol Genet 7:1851-1858, 1998
 
22) Gunel M, Laurans MS, Shin D, et al:KRIT1, a gene mutated in cerebral carnemous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A 99:10677-10682, 2002
PubMed
23) Vikkula M, Boon LM, Carraway KL, 3rd, et al:Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190, 1996
PubMed
24) Levy E, Carman MD, Fernandez-Madrid IJ, et al:Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-1126, 1990
PubMed
25) Levy E, Lopez-Otin C, Ghiso J, et al:Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 169:1771-1778, 1989
PubMed
26) Yamada M, Sodeyama N, Itoh Y, et al:Association of alpha 1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann Neurol 44:129-131, 1998
PubMed
27) Yamada M, Sodeyama N, Itoh Y, et al:Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 28:2219-2221, 1997
PubMed
28) Ikeda H, Sasaki T, Yoshimoto T, et al:Mapping of a familial moyamoya disease gene to chromosome 3p24. 2-p26. Am J Hum Genet 64:533-537, 1999
PubMed
29) Inoue TK, Ikezaki K, Sasazuki T, et al:Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15:179-182, 2000
PubMed
30) Yamauchi T, Tada M, Houkin K, et al:Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31:930-935, 2000
PubMed
31) Joutel A, Corpechot C, Ducros A, et al:Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707-710, 1996
PubMed
32) Kobayashi Y, Momoi MY, Tominaga K, et al:Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) . Am J Hum Genet 49:590-599, 1991
PubMed
33) Frosst P, Blom HJ, Milos R, et al:Acandidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113, 1995
 
34) Morita H, Kurihara H, Tsubaki S, et al:Methylene-tetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 18:1465-1469, 1998
PubMed
35) 中村祐輔, 中村雅美:ゲノムテクノロジーの光と影:ゲノムが世界を支配する.講談社, 東京, 150-177, 2001
 
P.29 掲載の参考文献
1) Drake CG:Progress in cerebrovascular disease. Management of cerebral aneurysm. Stroke 12:273-283, 1981
PubMed
2) International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 10;339:1725-1733, 1998
 
3) Bederson JB, Awad IA, Wiebers DO, et al:Recommendations for the management of patients with unruptured intracranial aneurysms:A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 102:2300-2308, 2000
PubMed
4) 日本脳ドック学会:脳ドックのあり方委員会:脳ドックのガイドライン 1997
 
5) 端和夫:未破裂脳動脈瘤の手術適応に関する考察. 脳外誌 7:441-445, 2002
 
6) 佐藤徹, 橋本信夫:無症候性脳動脈瘤の手術適応. 日医雑誌 127:NC63-65, 2002
 
7) Raaymakers TW, Rinkel GJ, Limburg M, et al:Mortality and morbidity of surgery for unruptured intracranial aneurysms:a meta-analysis. Stroke 29:1531-1538, 1998
PubMed
8) Yanaka K, Asakawa H, Noguchi S, et al:Intraoperative angiography evaluation of the microsurgical clipping of unruptured cerebral aneurysms. Neurol Med Chir 42:229-237, 2002
 
9) Dennis M, Bamford J, Sandercock P, et al:Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 21:848-853, 1990
PubMed
10) Moore WS, Barnett HJ, Beebe HG, et al:Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke 26:188-201, 1995
 
11) Langsfeld M, Gray-Weale AC, Lusby RJ:The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries. J Vasc Surg 9:548-557, 1989
PubMed
12) Imparato AM, Riles TS, Gorstein F:The carotid bifurcation plaque:pathologic findings associated with cerebral ischemia, Stroke 10:238-245, 1979
PubMed
13) North American Symptomatic Carotid Endarterectomy Trial Collaborators:Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445-453, 1991
PubMed
14) Fields WS, Maslenikov V, Meyer JS, et al:Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or non-surgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA 211:1993-2003, 1970
PubMed
15) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study:Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Athero-sclerosis Study. JAMA 273:1421-1428, 1995
 
16) Barnett HJ, Gunton RW, Eliasziw M, et al:Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA 283:1429-1436, 2000
PubMed
17) Yanaka K, Meguro K, Narushima K, et al:Combined carotid endarterectomy and coronary artery bypass graft. Neurol Med Chir 38:836-843, 1998
PubMed
18) Yanaka K, Sugimoto K, Yasuda M, et al:Current and future therapies for ischemic cerebrovascular disease. II. Surgery and new treatments on the horizon. Drugs Today 37:75-84, 2001
PubMed
19) The EC/IC Bypass Study Group:Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313:1191-1200, 1985
 
20) Sundt TM Jr:Was the international randomized trial of extracranial-intracranial arterial bypass representative of the population at risk?N Engl J Med 316:814-816, 1987
PubMed
21) 米川泰弘:浅側頭動脈-中大脳動脈Bypass手術の脳梗塞予防効果.神経進歩 32:320-327, 1988
 
22) Nussbaum ES, Erickson DL:Extracranial-intracranial bypass for ischemic cerebrovascular disease refractory to maximal medical therapy. Neurosurgery 46:37-43, 2000
PubMed
23) Kuroda S, Houkin K, Kamiyama H, et al:Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion:can acetazolamide test predict it? Stroke 32:2110-2116, 2001
 
24) Ogasawara K, Ogawa A, Yoshimoto T:cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion. A xenon-133 single-photon emission computed tomography study. Stroke 33:1857-1862, 2002
 
25) JET Study Group:Japanese CE-IC Bypass Trial (JET Study):中間解析結果 (第二報) .脳卒中の外科 2002 (印刷中)
 
P.35 掲載の参考文献
1) North American Symptomatic Carotid Endarterectomy Trial Collaborators:Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445-453, 1991
PubMed
2) European Carotid Surgery Trialists' Collaborative Group:MRC European Carotid Surgery Trial:Interim results for symptomatic patients with severe (70～99%) or with mild (0～29%) carotid stenosis. Lancet 337:1235-1243, 1991
 
3) Endarterectomy for asymptomatic carotid artery stenosis. Exective Commottee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273:1421-1428, 1995
 
4) Barnett HJM,:Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. NASCET collaborators. N Eng J Med 339:1415-1425, 1998
 
5) European Carotid Surgery Trialists' Collaborative Group:Randomised trial of endarterectomy for recentry symptomatic carotid stenosis:final results of the MRC European Carotid Surgery Trial(ECST) . Lancet 351:1379-1387, 1998
 
6) Hobson RW 2nd, Weiss DG, Fields WS, et al:Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Eng J Med 328:221-227, 1993
 
7) Biller J, Feinberg WM, Castaldo JE, et al:Guidelines for carotid endarterectomy. A statement for healthcare professionals from a special writing group of the stroke council, AHA. Circulation 97:501-509, 1998
 
8) Wennberg DE, Lucas FL, Birkmeyer JD, et al:Variation in carotid endarterectomy mortality in the Medicare poplulation:trial hospitals, volume, and patient characteristics. JAMA 279:1278-1281, 1998
 
9) Paciaroni M, Eliasziw M, Kappelle LJ, et al:Medical complications associated with carotid ensarterectomy. Stroke 30:1759-1763, 1999
PubMed
10) Bydon A, Thomas AJ, Seyfried D, et al:Carotid endarterectomy in patients with contralateral internal carotid artery occlusion without intraoperative shunting. Surg Neurol 57:325-330, 2002
PubMed
11) Pulli R, Dorrigo W, Barbanti E, et al:Carotid endarterectomy with contralateral carotid artery occlusion:is this a higher risk subgroup? Eur J Endovasc Surg 24:63-68, 2002
 
12) Harbaugh RE, Magnadottir HB:Carotid endarterectomy in high risk patients. Neurol Res 24:S66-70, 2002
PubMed
13) Rell T, Sheherdlmian S, Golchet P, et al:The safety of carotid endarterectomy in patients with preoperative renal dysfunction. Ann Vasc Surg 16:176-180, 2002
 
14) Gruntzig A, Hopff H:Perkutane Rekanalisation chronischer arterieller Verschlusse mit einem neuen Dilatationkatheter. Modifikation der Dotter-Technik. Dtsch med Wochenschr 99:2502-2511, 1974
PubMed
15) Kerber CW:Catheter dilatation of proximal stenosis during distal bifurcation endarterectomy. AJNR 1:348, 1980
PubMed
16) Bactmann DM:Transluminal dilatation for subclavian steal syndrome. AJR 135:995, 1980
 
17) Motarjeme A:Percutaneous transluminal angioplasty of the vertebral arteries. Radiology 139:715, 1981
PubMed
18) Haude M:Quantative analysis of elastic recoil after balloon angioplasty and after intracoronary inplantation of balloon-expandable Palmaz-Shatzstent. J Am Coll Cardiol 21:26, 1993
 
19) Palmaz JC:Balloon-expandable intravascular stent. AJR 150:1263, 1988
PubMed
20) Roubin GS:Intracoronary stenting for acute and threatened closure complicating Percutaneous transluminal coronary angioplasty. Circulation 85:916, 1992
PubMed
21) Roubin GS, Yadav S, Iyer SS, et al:Carotid stent supported angioplasty:aneurovascular intervention to prevent stroke. Am J Cardiol 78:8, 1996
 
22) Diethrich EB, Ndiye M, Reid DB:Stenting in the Carotid Artery:Initial Experience in 110 Patients. J Endovasc Surg 3:42, 1996
 
23) Henry M, Amor M, Knonaris C, et al:Angioplasty and stenting of xtracranial carotid arteries. Tex Heart Inst J 27:150-158, 2000
 
24) Al-Mubarak N, Colombo A, Gaines PA, et al:Multi-center evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol 39:841-846, 2002
 
25) Joint Officers of CNS and AANS:Carotid angioplasty and stent:An alternative to carotid endarterectomy. Neurosurgery 40:344, 1997
 
26) Wholey MH, Wholey M, Mathias K, et al:Global experience in cervical carotid artery stent placement. Cathet Cardiovasc Interv 50:161-167, 2000
 
27) Alberts MJ, McCann R, Smith TP, et al:A randomized trial:Carotid stenting versus endarterectomy in patients with symptomatic carotid stenosis, study designs. J neurovasc Dis 228-234, 1997
 
28) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid ad Vertebral Artery ransluminal Angioplasty Study (CA-VATAS):a randomised trial. Lancet 2;357:1729-1737, 2001
 
29) Hobson R:CREST(Carotid Revascularization Endarterectomy versus Stent Trial):background, design and current status. Semin Vasc Surg 13:139-143, 2000
PubMed
P.40 掲載の参考文献
1) Miyagi Y, Shima F, Ishido K, et al:Posteroventral pallidotomy for midebrain tremor after a ponitine hemorrhage. J Neurosurg 91:885-888, 1999
PubMed
2) Cooper IS, Upton ARM, Amin I:Chronic cerebellar stimulation (CCS) and deep brain stimulation (DBS) in involuntary movement disorders. Appl Neurophysiol 45:209-217, 1982
 
3) Andy OJ:Thalamic stimulation for control of movement disorders. Appl Neurophysiol 46:107-111, 1983
PubMed
4) Tsubokawa T, Katayama Y, Yamamoto T:Control of persistent hemiballismus by chronic thalamic stimulation. J Neurosurg 82:501-505, 1994
 
5) Geny C, N'Guyen JP, Cesaro P, Goujon C, Brugieres P, Degos JD:Thalamic stimulation for severe action tremor after lesion of the superior cerebellar peduncle. J Neurol Neurosurg Psychiat 59:641-642, 1995
PubMed
6) Tsubokawa T, Katayama Y:Surgical managements of posttraumatic tremor. Stereotactic thalamotomy and brain stimulation. Crit Rev Neurosurg 4:351-357, 1994
 
7) Nguyen JP, Degos J-D:Thalamic stimulation and proximal tremor. A specific target in the Vim nucelus. Arch Neurol 50:498-500, 1993
 
8) Kitagawa M, Murata J, Kikuchi S, et al:Deep brain stimulation of subthalamic area for severe proximal tremor. Neurology 55:114-116, 2000
PubMed
9) Kudo M, Goto S, Nishikawa S, et al:Bilatreral thalamic stimulation for Holmes' tremor caused by unilateral brainstem lesion. Mov Disord 16:170-174, 2001
 
10) Katayama Y, Fukaya C, Yamamoto T:Post-stroke pain control by chronic motor cortex stimulation:Neurological characteristics predicting favorable response. J Neurosurg 89:585-591, 1998
 
11) Katayama Y, Fukaya C, Yamamoto T:Control of post-stroke involuntary and voluntary movement disorders with deep brain or epidural cortical stimulation. Stereotact Funct Neurosurg 69:73-79, 1997
 
12) Katayama Y, Tsubokawa T, Yamamoto T:Chronic motor cortex stimulation for central deafferentation pain. Experience with bulbar pain secondary to Wallenberg syndrome. Sterotact Funct Neurosurg 62:295-299, 1994
PubMed
13) Katayama Y, Kasai M, Oshima H, et al:Subthalamic nucleus stimulation in Parkinson's disease. Benefits observed in levodopa-intolerant patients. J Neurosurg 95:213-221, 2001
PubMed
P.45 掲載の参考文献
1) 金谷春之ほか:高血圧性脳出血における新しい neurological grading および CT による血腫分類とその予後について.高血圧性脳出血の外科III, pp265-270, にゅーろん社, 東京, 1978.
 
2) 厚生省健康政策局研究開発振興課医療技術情報推進室監修:わかりやすい EBM 講座.東京, 厚生科学研究所, pp8-28, 2000
 
3) 「医療技術評価推進検討会」報告書について.平成11年3月.http://www1.mhlw.go.jp/houdou/1103/h0323-1_10.html
 
4) Mayberg MR, et al:Guidelines for the management of aneurysmal subarachnoid hemorrhage. Astatement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315-2328, 1994
 
5) Bederson JB, et al:Recommendations for the management of patients with unruptured intracranial aneurysms:A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 102:2300-2308, 2000
PubMed
6) Findlay JM and a Canadian Neurosurgical Society practice guideline review group:Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. Canadian J of Neurol Sci 24:161-170, 1997
 

第2章 脳血管障害のEBM

P.51 掲載の参考文献
1) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group:Tissue Plasminogen Activator for Acute Stroke. N Engl J Med 333:1581-1587, 1995
 
2) Adams HP, Brott TG, Furlan AJ, et al:Guidelines for Thrombolytic therapy for acute stroke:A supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 27:1711-1718, 1996
 
3) Hacke W, Kaste M, Fieschi C, et al:Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASSII). Lancet 352:1245-1251, 1998
 
4) Yamaguchi T, Hayakawa T, Kikuchi H:Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-272, 1993
 
5) Furlan A, Higashida R, Wechsler L, et al:Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study:A rondomised controlled trial. JAMA 282:2003-2011, 1999
PubMed
6) Wardlaw JM, del Zoppo G, Yamaguchi T:Thrombolysis for acute ischemic stroke(Cochrane Review). In:The Cochrane Library, Issue 2, 2002. Oxford:Update Software
 
7) Stroke Unit Trialists' Collaboration:Collaborative systematic review of the randomized trails of organized inpatients(stroke unit) care after stroke. BMJ 314:1151-1159, 1997
 
8) Karla L, Evans A, Perez I, et al:Alternative strategy for stroke care:a prospective randomized controlled trial. Lancet 356:894-899, 2000
 
9) Evans A, Harraf F, Donaldson N, et al:Randomised controlled study of stroke unit care versus stroke team care in different stroke subtypes. Stroke 33:449-455, 2002
PubMed
10) Stroke Unit Trialists' Collaboration. Organised inpatient(stroke unit) care for stroke(Cochrane Review). In:The Cochrane Library, Issue 2, 2002. Oxford:Update Software.
 
11) International Stroke Trial Collaborative Group:The International Stroke Trial (IST):a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. Lancet 349:1569-1581, 1997
 
12) TOAST Investigators:Low molecular weight heparinoid, ORG 10172(danaparoid), and outcome after acute ischemic stroke. JAMA 279:1265-1272, 1998
PubMed
13) Gubitz G, Counsell C, Sandercock P, et al:Antico-agulants for acute ischemic stroke(Cochrane Review). In:The Cochrane Library, Issue 2, 2002, Oxford:Update Software.
 
14) 田崎義昭, 小林祥泰, 東儀英夫ほか:脳血栓症急性期における抗トロンビン薬 MD-805 の臨床的有用性.プラセボを対照とした多施設二重盲検群間比較試験.医学のあゆみ 161:887-907, 1992
 
15) CAST Collaborative Group. CAST:randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischemic stroke. Lancet 349:1641-1649, 1997
 
16) Gubitz G, sandercock P, Counsell C:Antiplatelet therapy for acute ischemic stroke (Cochrane Review). In:The Cochrane Library, Issue 2, 2002. Oxford:Update Software.
 
17) 大友英一, 沓沢尚之, 小暮久也:脳血栓症急性期におけるOKY-046の臨床的有用性.プラセボを対象とした多施設二重盲検試験.臨床医薬 7:353-388, 1991
 
18) Blood pressure in Acute Stroke Collaboration (BASC):Interventions for deliberately altering blood pressure in acute stroke (Cochrane Review). In The Cochrane Library, Issue 2, 2002. Oxford:Update Software.
 
19) Horn J, Limburg M:Calcium antagonists for ischemic stroke. A systematic review. Stroke 32:570-576, 2001
PubMed
20) Broderick JP, Adams HP, Barsan W, et al:Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke 30:905-915, 1999
PubMed
21) Righetti E, Celani MG, Cantisani T, et al:Glycerol for acute stroke (Cochrane Review) . In:The Cochrane Library, Issue 2. 2002. Oxford:Update Software.
 
22) Bereczki D, Liu M, Fernandes G, et al:Cochrane Report. A systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 31:2719-1722, 2000
 
23) Qizilbash N, et al:Corticosteroids for acute ischemic stroke (Cochrane Review) Cochrane database Syst Rev. 1998
 
24) Poungvarin N, Bhoopat W, Viriyavej akul A, et al:Effects of dexamethasone in primary supratentorial intracerebral hemopphage. N Eng J Med 316:1229-1233, 1987
 
25) MCI-186 脳梗塞急性期研究会:大友英一:投稿中. 三菱ウェルファーマ, 社内資料
 
26) Yamaguchi T, Sano K, Takakura K, et al:Ebselen in acute ischemic stroke:aplacebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 29:12-17, 1998
 
27) 坂井文彦, 後藤文男, 高倉公朋:急性期脳出血・脳梗塞患者に対する nicaravene の至適用量の検討.後期第II相二重盲検試験.医学のあゆみ 175:767-798, 1995
 
28) Tirilazad International Steering Committee:Tirilazad mesylate in acute ischemic stroke:Asystematic review. Stroke 31:2257-2265, 2000
 
29) Asplund K, Israelsson K, Schampi I:Hemodilution for acute ischemic stroke (Cochrane Review). In:The Cochrane Library, Issue 2, 2002. Oxford:Update Software.
 
30) Liu M, Counsell C, Wardlaw J:Fibirinogen depleting agents for acute ischemci stroke (Cochrane Review). In:The Cochrane Library, Issue 2, 2002. Oxford;Update Software.
 
31) Sherman DG, et al:Intravenous ancrod for treatment of acute ischemic stroke:the STAT study:a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 283:2395-2403, 2000
PubMed
32) Haj at C, Hajat S, Shrama P:Effects of poststroke pyrexia on stroke outcome. A Meta-analysis of studies in patients. Stroke 31:410-414, 2000
 
33) Dippel DW, et al:Effect of paracetamol (acetoaminophen) on body temperature in acute ischemic stroke:a double-blind, randomized phase II clinical trial. Stroke 32:1607-1612, 2001
 
34) Kammersgaard LP, Rasmussen BH, Jorgensen HS, et al:Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through syrface colling:A case-control study. The Copenhagen Stroke Study. Stroke 31:2251-2256, 2000
 
35) Ronning OM, Guldvog B:Should stroke victims routinely receive supplemental oxygen? A Quasirandomised controlled trial. Stroke 30:2033-2037, 1999
 
36) Davenport RJ, Dennis MS, Warlow CP:Gastrointestinal hemorrhage after acute stroke. Stroke 27:421-424, 1996
PubMed
37) Arboix A, garcia-Eroles L, Massons JB, et al:Predictive factors of early seizures after acute cdere-brovascular disease. Stroke 28:1590-1594, 1997
 
P.60 掲載の参考文献
1) PROGRESS Collaborative Group:Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (9287):1033-1041, 2001
PubMed
2) Kannel WB, Wolf PA, McGee DL, et al:Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study JAMA 245 (12):1225-1229, 1981
PubMed
3) Levy D, et al:Cardiovascular risks:new insights from Framingham. Am Heart J 116:266-272, 1988
PubMed
4) Tanaka H, Ueda Y, Hayashi M, et al:Risk factors for cerebral hemorrhage and cerebral infarction in a Japarnese rural community. Stroke 13 (1):62-73, 1982
 
5) SHEP Cooperative Research Group:Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 265:3255-3264, 1991
 
6) Blood Pressure Lowering Treatment Trialistl's Collaboration:Effects of ACE inhibitors, calcium antagonist, and other blood-pressure-lowering drugs:results of prospectively designed overviews of randomized trials. Lancet 356:1955-1964, 2000
 
7) 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン 2000年版:日本高血圧学, 2000
 
8) Goldstein L, Adams R, Becker K, et al:Primary prevention of ischemic stroke-a statement for council of the American Heart Association. Stroke 32:280-299, 2001
PubMed
9) Kannel WB, McGee DL:Diabetes and cardiovascular disease. The Framingham study. JAMA 241 (19):2035-2038, 1979
 
10) Abbott RD, Donahue RP, MacMahon SW, et al:Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257 (7):949-952, 1987
PubMed
11) Barrett-Connor E, Khaw KT:Diabetes mellitus:an independent risk factor for stroke? Am J Epidemiol 128(1):116-123, 1988
PubMed
12) 大村隆夫, 上田一雄, 清原 裕:一般住民の22年間追跡調査における耐糖能異常と脳卒中発症の関連久山町研究.糖尿病 36(1):17-24, 1993
 
13) UK Prospective Diabetes Study(UKPDS) Group:Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35):prospective observational study. BMJ 321:405-412, 2000
 
14) UK Prospective Diabetes Study(UKPDS) Group:Association of systolic blood pressure With macrovascular and microvascular complications of type 2 diabetes (UKPDS 36):prospective observational study. BMJ 321:412-419, 2000
 
15) UK Prospective Diabetes Study(UKPDS) Group:Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38. BMJ 317 (7160):703-713, 1998
PubMed
16) Iso H, Jacobs DR Jr, Wentworth D, et al:Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for the multiple risk factor intervention trial. N Engl J Med 320 (14):904-910, 1989
 
17) Boysen G, Nyboe J, Appleyard M, et al:Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 19 (11):1345-1353, 1988
 
18) Sacco RL, Benson RT, Kargman DE, et al:High-density lipoprotein cholesterol and ischemic stroke in the elderly. The Northern Manhattan Stroke Study. JAMA 285 (21):2729-2735, 2001
PubMed
19) Shinkawa A, Ueda K, Kiyohara Y, et al:Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study Stroke 26 (3):380-385, 1995
 
20) 藤島正敏:日本人の脳卒中-特徴-.Prog Med 21:1225-1230, 2001
Medical*Online
21) Prospective Studies Collaboration:Cholesterol, diastolic blood pressure, and stroke, 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346 (8991-8992):1647-1653, 1995
 
22) Atkins D, Psaty BM, Koepsell TD, et al:Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med 119 (2):136-145, 1993
 
23) Scandinavian Simvastatin Survival Study Group:Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S) . Lancet 345:1274-1275, 1995
 
24) Shepherd J, et al:Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333:1301-1307, 1995
 
25) Plehn JE Davis BR, Sacks FM, et al:Reduction of stroke incidence after myocardial infarction with pravastatin:the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 99 (2):216-223, 1999
 
26) Long-term Intervention with Pravastatin in Ischemic Disease(LIPID) Study Group:Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339:1349-1357, 1998
 
27) White HD, Simens RJ, Anderson NE, et al:Pravastatin therapy and the risk of stroke. N Engl J Med 343:317-326, 2000
 
28) The Kyushu Lipid Intervention Study Group:Pravastatin use and risk of coronary events and cerebral infarction in Japanese men with moderate hypercholesterolemia:The Kyushu Lipid Interven-tion Study. J Atheroscler Thromb 7:110-121, 2000
 
29) Rubins HB, Robins SJ, Collins D, et al:Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 341:410-418, 1999
PubMed
30) Blauw GJ, Lagaay AM, Smelt AH, et al:Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28 (5):946-950, 1997
PubMed
31) Crouse JR 3rd, Byington RB Hoen HM, et al:Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 157 (12):1305-1310, 1997
 
32) Hebert PR, Gaziano JM, Chan KS, et al:Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278 (4):313-321, 1997
PubMed
33) Bucher HC, Griffith LE, Guyatt GH:Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med 128 (2):89-95, 1998
PubMed
34) Wolf PA, Dawber TR, Thomas HE Jr, et al:Epidemiologic assessment of chronic atrial fibrillation and risk of stroke:the Framingham study. Neurology 28 (10):973-977, 1978
PubMed
35) Wolf PA, Abbott RD, Kannel WB:Atrial fibrillation as an independent risk factor for stroke:The Framingham Study. Stroke 22 (8):983-988, 1991
PubMed
36) Yamanouchi H, Tomonaga M, Shimada H, et al:Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly. Stroke 20 (12):1653-1656, 1989
PubMed
37) Hart RG, Benavente O, McBride R, et al:Anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation:a meta-analysis. Ann Intern Med 131 (7):492-501, 1999
 
38) ACC/AHA/ESC Practice Guidelines:A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Circulation 104:2118-2150, 2001
 
39) Shinton R, Beevers G:Meta-analysis of relation between cigarette smoking and stroke. BMJ 298 (6676):789-794, 1989
PubMed
40) Nakayama T, Date C, Ybkoyama T, et al:A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 28 (1):45-52, 1997
 
41) Takeya Y, Popper JS, Shimizu Y, et al:Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California:incidence of stroke in Japan and Hawali. Stroke 15(1):15-23, 1984
 
42) Wolf PA, D'Agostino RB, Kannel WB, et al:Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 259 (7):1025-1029, 1988
PubMed
43) Wannamethee SG, Shaper AG, Whincup PH, et al:Smoking cessation and the risk of stroke in middle-aged men. JAMA 274 (2):155-160, 1995
PubMed
44) Wolf P, Clagett P, Easton D, et al:Prevention ischemic stroke in patients with prior stroke and transient ischemic attack. Stroke 30:1991-1994, 1999
 
45) Steering Committee of the Physiciarts:Health Study Research Group:Final report on the aspirin component of ongoing Physicians' Health Study. N Engl J Med 321:129-135, 1989
 
46) Iso H, et al:Prospective study of aspirin use and risk of stroke of women. Stroke 30:1764-1771 , 1999
PubMed
47) 佐藤 洋:Symposium:第13回血栓症セミナー. 脳塞栓症の原因と治療-非弁膜症性心房細動. Therapeutic Research 21:416-422, 2000
 
48) Gueyffier F, Boissel JP, Boutitie E et al:Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (Individual Data Analysis of Antihypertensive intervention trials) Project Collaborators. Stroke 28 (12):2557-2562, 1997
 
49) Hansson L, Zanchetti A, Carruthers SG, et al:Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351 (9118):1755-1762, 1998
 
50) Rodgers A, MacMahon S, Gamble G, et al:Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ 313 (7050):147, 1996
 
51) Irie K, Yamaguchi T, Minematsu K, et al:The J-curve phenomenon in stroke recurrence. Stroke 24 (12):1844-1849, 1993
 
52) Alter M, Lai SM, Friday G, et al:Stroke recurrence in diabetics. Does control of blood glucose reduce risk? Stroke 28 (6):1153-1157, 1997
PubMed
53) EAFT (European Atrial Fibrillation Trial) Study Group:Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke Lancet 342:1255-1262, 1993
PubMed
54) Stroke Prevention in Atrial Fibrillation Investigators:Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation:Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 348 (9028) 633-638, 1996
 
55) Yamaguchi T:for Japanese Nonvalvular Atrial Fibrillation Embolism-Secondary Prevention Cooperative Study Group:Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. A multicenter, prospective, randomized trial. Stroke 31:817-821, 2000
 
56) Yasaka M, Minematsu K, Yamaguchi T:Optimal intensity of international normalized ratio in Warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40 (12):1183-1188, 2001
PubMed
57) Antithromobotic Trialists' ollaboration:Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86, 2002
 
58) Antiplatelet Trialists' Collaboration:Collaborative overview of randomized trials of antiplatelet therapy-I:Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81-106, 1994
PubMed
59) Gotoh E et al:Cilostazol stroke prevention study:a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 9:147-157, 2000
 
P.67 掲載の参考文献
1) Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 339 (24):1725-33, 1998
 
2) King JT, Jr., Berlin JA, Flamm ES:Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms:a meta-analysis, J Neurosurg 81 (6):837-42, 1994
PubMed
3) Raaymakers TW, Rinkel GJ, Limburg M, Algra A:Mortality and morbidity of surgery for unruptured intracranial aneurysms:a meta-analysis. Stroke 29 (8):1531-8, 1998
PubMed
4) Chyatte D, Porterfield R:Functional outcome after repair of unruptured intracranial aneurysms. J Neurosurg 94 (3):417-21, 2001
PubMed
5) David CA, Vishteh AG, Spetzler RE Lemole M, Lawton MT, Partovi S:Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg 91 (3):396-401, 1999
 
6) Brilstra EH, Rinkel GJ, van der Graaf Y, van Rooij WJ, Algra A:Treatment of intracranial aneurysms by embolization with coils:a systematic review. Stroke, 30 (2):470-6, 1999
PubMed
7) Bederson JB, Awad IA, Wiebers DO, et al:Recommendations for the management of patients with unruptured intracranial aneurysms:A Statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 31 (11):2742-50, 2000
PubMed
8) Mayberg MR, Batjer HH, Dacey R, et al:Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Cirulation 90 (5):2592-605, 1994
 
9) de Gans K, Nieuwkamp DJ, Rinkel GJ, Algra A:Timing of aneurysm surgery in subarachoid hemorrhage:a systematic review of the literature. Neurosurgery 50 (2):336-40;discussion 340-2, 2002
 
10) Ogawa A, Suzuki M, Ogasawara K:Aneurysms at nonbranching sites in the surpaclinoid portion of the internal carotid artery:internal carotid artery trunk aneurysms. Neurosurgery 47 (3):578-83;discussion 583-6, 2000
 
11) Hacein-Bey L, Connolly ES, Jr., Duong H, et al:Treatment of inoperable carotid aneurysms with endovascular carotid occlusion after extracranial-intracranial bypass surgery. Neurosurgery 41 (6):1225-31;discussion 1231-4, 1997
 
12) Vinuela E Duckwiler G, Mawad M:Guglielmi detachable coil embolization of acute intracranial aneurysm:perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 86 (3):475-82, 1997
 
13) Hope JK, Byrne JV, Molyneux AJ:Factors influencing successful angiographic occlusion of aneurysms treated by coil embolization. AJNR Am J Neuroradiol 20 (3):391-9, 1999
PubMed
14) Raftopoulos C, Mathurin P, Boscherini D, Bill a RE Van Boven M, Hantson P:Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option. J Neurosurg 93 (2):175-82, 2000
 
15) Sluzewski M, Bosch JA, van Rooij WJ, Nussen PC, Wijnalda D:Rupture of intracranial aneurysms during treatment with Guglielmi detachable coils:incidence, outcome, and risk factors. J Neurosurg 94 (2):238-40, 2001
 
16) Lin T, Fox AJ, Drake CG:Regrowth of aneurysm sacs from residual neck following aneurysm clipping. J Neurosurg 70 (4):556-60, 1989
PubMed
17) Ng P, Khangure MS, Phatouros CC, Bynevelt M, ApSimon H, McAuliffe W:Endovascular treatment of intracranial aneurysms with Guglielmi detachable coils:analysis of midterm angiographic and clinical outcomes. Stroke 33 (1):210-7, 2002
PubMed
18) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 (7):445-53, 1991
 
19) Barnett HJ, Taylor DW, Eliasziw M, et al:Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339 (20):1415-25, 1998
PubMed
20) Ferguson GG, Eliasziw M, Barr HW, et al:The North American Symptomatic Carotid Endarterectomy Trial:surgical results in 1415 patients. Stroke 30 (9):1751-8, 1999
PubMed
21) MRC European Carotid Surgery Trial:interim results for symptomatic patients with severe (70～ 99%) or with mild (0～29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 337 (8752):1235-43, 1991
 
22) Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Jama 273 (18):1421-8, 1995
PubMed
23) Rothwell PM, Slattery J, Warlow CP:A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 27 (2):260-5, 1996
PubMed
24) Rothwell PM, Slattery J, Warlow CP:A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. Stroke 27 (2):266-9, 1996
PubMed
25) Kachel R:Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 3 (1):22-30, 1996
PubMed
26) Phatouros CC, Higashida RT, Malek AM, et al:Carotid artery stent placement for atherosclerotic disease:rationale, technique, and current status. Radiology 217 (1):26-41, 2000
PubMed
27) Sundt TM, Jr., Meyer FB, Piepgras DG, Fode NC, Ebesold MJ, Marsh WR:Risk factors and operative results. In:Weber, ed. Sundt's occlusive cerebrovascular disease. Philadelphia:Saunders, 241-247, 1994
 
28) Teitelbaum GP, Letkowitz MA, Giannotta SL:Carotid angioplasty and stenting in high-risk patients. Surg Neurol 50 (4):300-11;discussion 311-2, 1998
 
29) Mathur A, Roubin GS, Iyer SS, et al:Predictors of stroke complicating carotid artery stenting. Circulation 97 (13):1239-45, 1998
PubMed
30) Mathur A, Roubin GS, Gomez CR, et al:Elective carotid artery stenting in the presence of contralaleral occlusion. Am J Cardiol 81 (11):1315-7, 1998
PubMed
31) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The ECIIC Bypass Study Group. N Engl J Med 313 (19):1191-200, 1985
 
32) Powers WJ, Tempel LW, Grubb RL, Jr:Influence of cerebral hemodynamics on stroke risk:one-year follow-up of 30 medically treated patients. Ann Neurol 25 (4):325-30, 1989
PubMed
33) Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW:Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 79 (4):483-9, 1993
PubMed
34) Yamauchi H, Fukuyama H, Nagahaina Y, et al:Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 61 (1):18-25, 1996
 

第3章 新しい認識に基づいた脳血管障害の病因と治療

P.74 掲載の参考文献
1) 健康・体力づくり事業財団:健康日本21 (21世紀における国民健康づくり運動について健康日本21企画検討会・健康日本21計画策定検討会報告書, 2000
 
2) PROGRESS Collaborative Group:Randomized trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033-1041, 2001
PubMed
3) Yamaguchi T for Japanese non valvular atrial fibrillation-embolism secondary prevetion study group:Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibllilation;multicenter prospective randomized trial. Stroke 31:817-821, 2000
 
4) Kinoshita T, Okudera Y, Tamura H, et al:Assessment of lacunar hemorrhage associated with hypertensive stroke by echo planar gradient-T2* weighted MRI. Stroke 31:1646-1650, 2000
 
5) 金谷春之:高血圧性脳出血の治療の現況-全国調査の成績より-.脳卒中 12:509-524, 1990
 
6) St. Louis EK, Wijdicks EFM, Li H, et al:Predicting neurologic deterioration in patients with cerebellar hematomas. Neurology 51 (Suppl):225-261, 1998
 
7) Major ongoing stroke trials:Surgical trial in intracerebral haemorrhage (STICH) . Stroke 30:490, 1999
 
P.80 掲載の参考文献
1) Phillips LH 2nd, Whisnant JP, O:Fallon WM, et al:The unchanging pattern of subarachnoid hemorrhage in a community. Neurology 30:1034-1040, 1980
 
2) 塩川芳昭, 斉藤勇:脳動脈瘤の疫学.Clinical Neuroscience 17:610-615, 1999
 
3) Mayberg MR, Batjer HH, Dacey R, et al:Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315-2328, 1994
PubMed
4) van Gijn J, Rinkel GJ:Subarachnoid haemorrhage:diagnosis, causes and management. Brain 124:249-278, 2001
PubMed
5) Brega KE, Seltzer WK, Munro LG, et al:Genotypic variations of types III collagen in patients with cerebral aneurysms. Surg Neurol 46:253-236, 1996
 
6) Connolly ES Jr, Fiore AJ, Winfree CJ, et al:Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery 40:903-908, 1997
PubMed
7) Kissela BM, Sauerbeck L, Woo D:Subarachoid Hemorrhage:A Preventable Disease With a Heritable Component. Stroke 33:1321-1326, 2002
 
8) Hashimoto N, Handa H, Hazama F:Experimentally induced cerebral aneurysms in rats. Surg Neurol 10:3-8, 1978
PubMed
9) Fukuda S, Hashimoto N, Naritomi H, et al:Prevention of rat cerebral aneurysm forrnation by inhibition of nitric oxide synthase. Circulation. 101:2532-2538, 2000
PubMed
10) Mayberg MR, Batj er HH, Dacey R, et al:Guide-lines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315; 2328, 1994
 
11) Fujii Y, Takeuchi S, Sasaki O, et al:Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 84:35-42, 1996
PubMed
12) Kassell NF, Torner JC, Haley EC Jr, et al:The International Cooperative Study on the fiming of Aneurysm Surgery. Part 1:Overall management results. J Neurosurg 73:18-36, 1990
 
13) Takagi K, Tamura A, Nakagomi T, et al:How should a subarachnoid hemorrhage grading scale be determined? A combinatorial approach based solely on the Glasgow Coma Scale. J Neurosurg 90:680-687, 1999
PubMed
14) Ogilvy CS, Carter BS, Kaplan S, et al:Temporary vessel occlusion for aneurysm surgery:risk factors for stroke in patients protected by induced hypothermia and hypertension artd intravenous mannitol administration. J Neurosurg 84:785-791, 1996
 
15) Todd NV, Tocher JL, Jones P, et al:Outcome following aneurysm wrapping:a 10-year follow-up review of clipped and wrapped aneurysms. J Neurosurg 70:841-846, 1989
PubMed
16) Kinugasa K, Mandai S, Terai Y, et al:Direct thrombosis of aneurysms with cellulose acetate polymer. Part II:Preliminary clinical experience. J Neurosurg 77:501-507, 1992
PubMed
17) Raymond J, Roy D:Safety and efficacy of endovascular treatment of acutely ruptured aneurysms. Neurosurgery 41:1235-1245, 1997
PubMed
18) Hayakawa M, Murayalna Y, Duckwiler GR, et al:Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system. J Neurosurg 93:561-568, 2000
 
19) Sasaki T, Kodama N, Kawakami M, et al:Urokinase cistemal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage:a study of urokinase concentration and the fibrinolytic system Stroke 31:1256-1262, 2000
 
20) Sawada M, Hashimoto N, Tsukahara T, et al:Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir (Wien) 139:706-711, 1997
PubMed
P.89 掲載の参考文献
1) Bederson JB, et al:Recommendations for the management of patients with unruptured intracranial aneurysms. A statement for healthcare professionals from the stroke council of the American heart Association. Stroke 31:2741-2750, 2000
 
2) 日本脳ドック学会:脳ドックガイドライン.1999
 
3) UCAS Japan 事務局:日本未破裂脳動脈瘤悉皆調査の現況-中間報告I-脳外誌 11:256-264, 2002
 
4) Weir B:Unruptured intracranial aneurysms:a review. J Neurosurg 96:3-42, 2002
PubMed
5) Raaymakers TW, Rinkel GJ, Limburg M, et al:Mortality and morbidity of surgery for unruptured intracranial aneurysms:a meta-analysis. Stroke 29:1531-1538, 1998
PubMed
6) Raaymakers TW:Functional outcome and quality of life after angiography and operation for unruptured intracranial aneurysms. On behalf of the MARS Study Group. J Neurol Neurosurg Psychiatry 68:571-576, 2000
 
7) The International Study of Unruptured Intracranial Aneurysms Investigators:Unruptured Intracranial Aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 340:1439-1442, 1998
 
8) Juvela S, Porras M, Poussa K:Natural history of unruptured intracranial aneurysms:probability of and risk factors for aneurysm rupture. J Neurosurg 93:379-387, 2000
PubMed
9) Rinkel GJ, Djibuti M, Algra A, et al:Prevalence and risk of rupture of intracranial aneurysms:a systematic review. Stroke 29:251-256, 1998
PubMed
10) Tsutsumi K, Ueki K, Morita A, et al:Risk of rupture from incidental cerebral aneurysms. J Neurosurg 93:550-553, 2000
PubMed
11) Wiebers DO, et al:The significance of unruptured intracranial saccular aneurysms. J Neurosurg 66:23-29, 1987
PubMed
12) Yasui N, et al:Long-term follow-up study of unruptured intracranial aneurysms. Neurosurgery 40:1155-1160, 1997
PubMed
13) Iwamoto H, Kiyohara Y, Fujishima M, et al:Prevalence of intracranial saccular aneurysms in a Japanese community based on a consecutive autopsy series during a 30-year observation period. The Hisayama study. Stroke 30:1390-1395, 1999
 
14) Johnston SC, Zhao S, Dudley RA, et al:Treatment of unruptured cerebral aneurysms in California. Stroke 32:597-605, 2001
PubMed
15) King JT, Jr., Berlin JA, Flamm ES:Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms:ameta-analysis. J Neurosurg 81:837-842, 1994
 
16) Orz YI, Hongo K, Tanaka Y, et al:Risks of surgery for patients With unruptured intracranial aneurysms. Surg Neurol 53:21-27;discussion 27-29, 2000
 
17) Solomon RA, et al:Surgical management of unruptured intracranial aneurysms. J Neurosurg 80:440-446, 1994
PubMed
18) Wirth FP, et al:Surgical treatment of incidental intracranial aneurysms. Neurosurgery 507-511, 1983
PubMed
19) King JT, Jr., Glick HA, Mason TJ, et al:Elective surgery for asymptomatic, unruptured, intracranial aneurysms:a cost-effectiveness analysis. J Neurosurg 83:403-412, 1995
PubMed
20) Tsutsumi K, Ueki K, Usui M, et al:Risk of subarachnoid hemorrhage after surgical treatment of unruptured cerebral aneurysms. Stroke 30:1181-1184, 1999
PubMed
21) The New England Journal of Medicine report on unruptured intracranial aneurysms:acritique. Surg Neurol 51:227-229, 1999
 
22) Ingall T, Asplund K, Mahonen M, et al:A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 31:1054-1061, 2000
PubMed
23) Chang HS, et al:Qualification of operative benefit or unrupted cerebral aneurysms:a theoritical approach. J Neurosurg 83:413-420, 1995
 
24) Mitchell P, Jakubowski J:Risk analysis of treatment of unruptured aneurysms. J Neurol Neurosurg Psychiatry 68:577-580, 2000
PubMed
25) Kataoka K, Taneda M, Asai T, et al:Difference in nature of ruptured and unruptured cerebral aneurysms. Lancet 355:203, 2000
PubMed
26) Yoshimoto Y, Wakai S:Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms. A mathematical model. Stroke 30:1621-1627, 1999
PubMed
27) The magnetic resonance angiography in relatives of patients with subarachnoid hemorrhage study group:Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage. N Engl J Med 341:1344-50, 1999
 
28) van der Schaaf IC, Brilstra EH, Rinkel GJ, et al:Quality of life, anxiety, and depression in patients with an untreated intracranial aneurysm or arteriovenous malformation. Stroke 33:440-443, 2002
PubMed
P.94 掲載の参考文献
1) The National Institute of Neurological Disorders and Stroke:Classification of cerebrovascular diseases III. Stroke 21:637-676, 1990
PubMed
2) Dyken ML, Comeally M, Haerer AF, et al:Cooperative study of hospital frequency and character of transient ischemic attacks, I:background, organization, and clinical survey. JAMA 237:882-886, 1977
 
3) Antonio C, Carlos SK, Joseph CM, et al:Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke:a report of the stroke council, American Heart Association. Stroke 28:1480-1497, 1997
 
4) Kidwell CS, Alger JR, Di Salle F, et al:Diffusion MRI in patients with transient ischemic attacks. Stroke 30:1174-1180, 1999
PubMed
5) 福内靖男:TIAの成因:Thromboembolism説と Hemodynamic説.日本臨床 40:2202-2207, 1982
Medical*Online
6) 野川茂, 福内靖男:一過性脳虚血発作の原因・予後と対応策.別冊・医学のあゆみ.神経疾患-state of arts. pp409-413, 医歯薬出版, 1999年
 
7) 棚橋紀夫, 福内靖男:成因別のTIA対策. Hemodynamic TIA.現代医療 25:1309-1312, 1993
 
8) Bogousslavsky J, Van Melle G, Regli F, et al:The Lausanne Stroke registry:analysis of 1000 consecutive patients with first stroke. Stroke 19:1083-1092, 1988
 
9) Feinberg WM, Albers GW, Bamett HJM, et al:Guideline for the management of transient ischemic attacks. From the Ad Hoc Committee on guideline for the management of transient ischemic attacks of the stroke council of the American heart Association. Stroke 25:1320-1335, 1994
 
10) Sempere AP, Duarte J, Cabezas C, et al:Epipathogenesis of transient ischemic attacks and minor ischemic strokes. A community-based study in Segovia, Spain. Stroke 29:40-45, 1998
 
11) Donnan GA, O'Malley HM, Quang L, et al:The capsular waring syndrome:pathogenesis and clinical features. Neurology 43:957-962, 1993
 
12) 栗山良鉱ら:内頸動脈系TIA発現に関与する血行力学的因子.脳卒中 9:463-468, 1987
 
13) 棚橋紀夫, 後藤文男, 冨田稔ら:一過性脳虚血発作患者の赤血球aggregabilityについて.脳卒中 12:396-400, 1990
 
14) Albers GW, Hart RG, Lutsep HL, et al:Supplement to the guidelines for the management of transient ischemic attacks. A statement from the ad Hoc Committee on Guidelines for the management of transient ischemic attacks, stroke council, American Heart Association. Stroke 30:2502-2511, 1999
 
15) Wolf PA, Clagett P, Easton JD, et al:Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30:1991-1994, 1999
 
16) Antithrombotic Trialists' Collaboration:Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86, 2002
PubMed
17) North American symptomatic Carotid Endarterectomy Trial Collaborators:Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445-453, 1991
PubMed
18) European Carotid Surgery Trialists' Collaborative Group:MRC European carotid Surgery Trial:interim results for symptomatic patients with severe (70-90%) or with mild (0-29%) carotid stenosis. Lancet 337:1235-1243, 1991
 
19) Doman GA, Davis SM, Chambers BR, et al:Commentary:surgery for prevention of stroke. Lancet 351:1372-1373, 1998
 
P.99 掲載の参考文献
1) Committee Established by the Director of the NINDS:Classification of cerebrovascular diseases III. Stroke 21:637-676, 1990
 
2) CAST(Chinese Acute Stroke Trial) Collaborative Group. CAST:Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641-1649, 1997
 
3) International Stroke Trial Collaborative Group:The International Stroke Trial (IST):a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 349:1569-1581, 1997
 
4) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group:Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
 
5) 大友英一, 沓沢尚之, 小暮久也ほか:脳血栓急性期における OKY-046 の臨床的有用性-プラセボを対照とした多施設二重盲検試験-.臨床医薬 7:353-388, 1991
 
6) 田崎義昭, 小林祥泰, 東儀英夫ほか:脳血栓症急性期に対する抗トロンビン薬 MD-805 の臨床的有用性-プラセボを対照とした多施設二重盲検群間比較試験-医学のあゆみ 161:887-907, 1992
 
7) The Publicatiom Committee for the Trial of ORG 10172 in Acute Ischemic Stroke Treatment (TOAST) Investigators:Low molecular weight heparinoid, ORG 10172 (Danaparoid), and outcome after acute ischemic stroke. JAMA 279:1266-1272, 1998
 
8) Fressinaud E, Baruch D, Girma JP, et al:von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein II b III a as well as glycoprotein I b. J Lab Clin Med, 112:58-67, 1988
 
9) Nomura E, Kohriyama T, Kozuka K, et al:Sequential changes in von Willebrand factor and soluble thrombomodulin in acute ischemic stroke. J Stroke Cerebrovasc Dis 10:257-264, 2001
PubMed
10) Kozuka K, Kohriyama T, Nomura E, et al:Endothelial markers and adhesion molecules in acute ischemic stroke-sequential change and differences in stroke subtype. Atherosclerosis 161:161-168, 2002
PubMed
11) The Abciximab in Ischemic Stroke Investigators:Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-cntrolled, dose-escalation study, Stroke 31:601-609, 2000
PubMed
12) Eto K, Isshiki T, Yamamoto H, et al:AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndrome. Arterioscler Thromb Vasc Biol 19:877-882, 1999
 
13) Endres M, Laufs U, Huang Z, et al:Stroke protection by 3-hydroxy-3-methylglutaryl(HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880-8885, 1998
PubMed
14) Furlan A, Higashida R, Wechsler L, et al:Intraarterial prourokinase for acute ischemic stroke. The PROACT II Study:A randomised controlled trial. JAMA 282:2003-2011, 1999
PubMed
15) 大坪亮一, 峰松一夫, 小林祥泰, 脳卒中急性期データベースの構築に関する研究班:虚血性脳血管障害急性期患者における出血性梗塞とその関連因子.脳卒中 23:227-233, 2001
 
16) 棚橋紀夫:脳梗塞の抗凝固療法・抗血小板療法.神経・筋疾患の最新治療, 先端医療技術研究所, 東京, p73-77, 2001
 
17) 上塚芳郎:新しい抗血栓薬 各論1) 抗凝固薬 (3) トロンボモジュリン.医薬ジャーナル 35:1067-1072, 1999
 

第4章 脳血管障害の新しい画像診断法

P.107 掲載の参考文献
1) 及川博文:頭部CT, 超急性期脳梗塞のCT診断. 佐々木真理編集:片田和廣監修:MDCT 徹底攻略マニュアル, メジカルビュー社, 東京, p72-77, 2002
 
2) Nabavi DG, Cenic A, Craen RA, et al:CT assessment of cerebral parfusuion:experimental validation and initial clinical experience. Radiology 213:141-149, 1999
PubMed
3) 田圭元将吾, 平松慶博:三次元CT画像の作成技術. 森山紀之監修:山之内製薬株式会社企画:実践三次元CT診断-Clinical 3D-CT imaging, 医療科学社, 東京, p114-123, 1999
 
4) 板東道夫:Volume rendering による脳表MR angiography の作成. MRI TODAY 6:15-18, 1999
 
5) 佐藤嘉伸:わかりやすい3次元画像処理の基礎:等方向ボクセルの利点について.画像診断 20:499-508, 2000
 
6) Kobayashi N, Hosoya T, Adachi M, et al:Virtual MR microscopy for unruptured aneurysm. Comput Methods Programs Biomed. 66:99-103, 2001
PubMed
7) 片田和廣ほか:中枢神経系の 3D-CT angiography. 画像診断20:509-515, 2000
 
P.112 掲載の参考文献
1) Schaefer PW, Grant PE, Gonzalez RG:Diffusion-weighted MR imaging of the brain. Radiology 217:331-345, 2000
PubMed
2) Gonzalez RG, Schaefer PW, Buonanno FS, et al:Diffusion-weighted MR imaging:diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 210:155-162, 1999
PubMed
3) Sorensen AG, Buonanno FS, Gonzalez RG, et al:Hyperacute stroke:evaluation with combined multisection diffusion-weighted and hemody-namically weighted echo-planar MR imaging. Radiolgy 199:391-401, 1996
 
4) Yoshikawa T, Abe O, Tsuchiya K, et al:Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 44 (6):481-8, 2002
PubMed
5) Sorensen AG, Copen WA, Oestergaard L, et al:Hyperacute stroke:simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210:519-527, 1999
 
6) Arbab AS, Aoki S, Toyama K, et al:Quantitative measurement of regional cerebral blood flow with flow-sensitive alternating inversion recovery imaging:comparison With [iodine 123]-iodoarnphetamin single photon emission CT AJNR 23:381-388, 2002
PubMed
7) Serfaty JM, Chirossel P, Chevallier JM, et al:Accuracy of three-dimensional gadolinium-enhanced MR angiography in the assessment of extracranial carotid artery disease. AJR Am J Roentgenol 175:455-63, 2000
PubMed
8) Willig DS, Turski PA, Frayne R, et al:Contrast-enhanced 3D MR DSA of the carotid artery bifurcation:preliminary study of comparison with unenhanced 2D and 3D time-of-flight MR angiography. Radiology. 208 (2):447-51, 1998
PubMed
9) Aoki S, Nakaj ima H, Kumagai H, Araki T:Dynamic contrast-enhanced MR angiography and MR imaging of the carotid artery:high-resolution sequences in different acquisition planes. AJNR 21 (2):381-5, 2000
 
10) 青木茂樹:頸部 MRA.興椙征典編.脳脊髄MRAの読み方.中外医学社 53-70, 2000
 
11) Aoki S, Ybshikawa T, Hori M, et al:2D thick-slice MR digital subtraction angiography for assessment of cerebrovascular occlusive diseases. Eur Radiol 10:1858-1864, 2000
PubMed
12) Aoki S, Yoshikawa T, Hori M, et al:MR digital subtraction angiography for the assessment of cranial arteriovenous malformations and fistulas. AJR Am J Roentgenol 175 (2):451-3, 2000
PubMed
13) Yang Q, Tress B, Barber PA, et al:Serial study of apparent diffusion coefficient and anisotropy in patients with acute stroke. Stroke 30:2382-2390, 1999
PubMed
14) Werring DJ, Toosy AT, Clark CA, et al:Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol, Neurosurg, Psychiat 69:269-272, 2000
PubMed
15) Toyoda K, Ida M, Fukuda K:FLAIR intraarterial signal:early sign of hyperacute cerebral ischemia. AJNR 22:1021-9, 2001
PubMed
16) Aoki S, Aoki K, Ohsawa S, Nakajima H, Araki T:Dynamic MR images of the carotid wall. J Magnetic Reson Imaging 9:420-427, 1999
 
17) Yuan C, Beach KW, Smith LH Jr, Hatsukami TS:Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 98 (24):2666-71, 1998
PubMed
18) Aoki S, Shirouzu I, Sasaki Y, et al:Enhancement of the intracranial arterial wall at MR imaging:relationship to cerebral atherosclerosis. Radiology 194 (2):477-81, 1995
PubMed
19) Aoki S, Hayashi N, Abe O, et al:Radiation induced arteritis:thickened wall with prominent enhancement on cranial MR images-report of five cases and comparison with 18 cases of moyamoya disease. Radiology 223:683-688, 2002
PubMed
20) 井田正博:脳虚血超急性期における proton MR spectroscopy. 神経放射線学会秋田, 2002
 
P.118 掲載の参考文献
1) Harada A, Fujii Y, Yoneoka Y, et al:High-field magnetic resonance imaging in patients with moyamoya disease. J Neurosurg 94:233-237, 2001
PubMed
2) Nakada T, Matsuzawa H, Kwee IL:Magnetic resonance axonography of the rat spinal cord. Neuroreport 5:2053-2056, 1994
PubMed
3) Igarashi H, Katayama Y, Tsuganezawa T, et al:Three-dimensional anisotropy contrast (3DAC) magnetic resonance imaging of the human brain:application to assess Wallerian degeneration. Intern Med 37:662-668, 1998
PubMed
4) Inoue T, Shimizu H, Yoshimoto T:Imaging the pyrarnidal tract in patients with brain tumors. Clin Neurol Neurosurg 101:4-10, 1999
PubMed
5) Inoue T, Shimizu H, Yoshimoto T, et al:Spatial functional distribution in the corticospinal tract at the corona radiata:a three-dimensional anisotropy contrast study. Neurol Med Chir (Tokyo) 41:293-298;discussion 298-299, 2001
 
6) Kim SG:Quantification of relative cerebral blood flow change by flow-sensitive altemating inversion recovery (FAIR) technique:application to functional mapping. Magn Reson Med 34:293-301, 1995
 
7) Stark DD, Bradley WG:Magnetic resonance imaging, in Corra E(ed). St. Louis:Greenwood, G., 1999, Vol III, p 1302
 
P.124 掲載の参考文献
1) Fahrig R, Fox AJ, Lownie S, et al:Use of a C-arm system to generate ture three dimensional computed rotational angiograms:preliminary in vitro and in vivo results. AJNR Am J Neuroradiol 18:1507-1514, 1997
 
2) Anxionnat R, Bracard S, Ducrocq X, et al:Intracranial aneurysms:clinical value of 3D digital subtraction angiography in the therapeutic decision and endovascular treatment. Radiology 218:799-808, 2001
PubMed
3) 安陪等思, 広畑 優, 谷川 仁ほか:Rotational Three-dimensional Cerebral Angiography 回転三次元脳血管撮影.映像情報 Medical 33:977-983, 2001
 
4) 安陪等思, 田中法瑞, 広畑 優ほか:脳血管撮影とIVR.臨床画像 16:524-533, 2000
 
5) Abe T, Hirohata M, Tanaka N, et al:Clinical benefits of rotational 3D angiography in endovascular treatment of ruptured cerebral aneurysm. AJNR Am J Neuroradiol 23:686-688, 2002
PubMed
6) Betting F, Moris G, Knoplioch J, et al:Evaluation of a new method for stenosis quantification from 3D X-ray angiography images. Proc SPIE Med Imaging 4319:194-202, 2001
 
7) 朝比奈宏:デジタル透視・撮影の可能な直接変換方式のX線平面検出器.メディカルレビュー 23:2-8, 1999
 
8) Koenig TR, Wolff D, Mettler EA, et al:Skin injuries from fluoroscopically guided procedures:Part 1, Characteristics of radiation injury. AJR 177:3-11, 2001
 
9) Koenig TR, Mettler EA, Wagner LK:Skin injuries from fluoroscopically guided procedures:Part 2, Review of 73 cases and recommendations for minimizing dose delivered to patients. AJR 177:13-20, 2001
 
P.132 掲載の参考文献
1) 日本脳神経超音波学会頸動脈エコー検査ガイドライン作成委員会:頸動脈エコーによる動脈硬化性病変評価のガイドライン (案) .Neurosonology 15:20-33, 2002
Medical*Online
2) Koga M, Kimura K, Minematsu K, et al:Diagnosis of internal carotid artery stenosis greater than 70% with power Doppler duplex sonography. AJNR. 22:413-417, 2001
PubMed
3) Todo K, Watanabe M, Fukunaga R, et al:Imaging of distal carotid artery by ultrasonography with a 3.5-MHz convex probe. Stroke 33:1792-1794, 2002
PubMed
4) Kimura K, Yasaka M, Moriyasu H, et al:Ultrasono-graphic evaluation of vertebral artery to detect vertebrobasilar axis occlusion. Stroke 25:1006-1009, 1994
 
5) Itoh T, Matsumoto M, Handa N, et al:Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. Stroke 24:1192-1195, 1993
PubMed
6) Kimura K, Yasaka M, Wada K, et al:Diagnosis of middle cerebral artery stenosis by transcranial color-coded real-time sonography. AJNR. 19:1893-1896, 1998
 
7) Kimura K, Minematsu K, Yasaka M, et al:Evaluation of posterior cerebral artery flow velocity by transcranial color-coded real-time sonography. Ultrasound in Med & Biol. 26:195-199, 2000
PubMed
8) Mas J-L. Arquizan C, Lamy C, et al:Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. New Engl J. Med. 345:1740-1746, 2001
PubMed
9) Ohgi S, et al:Exploration of pulmonary embolic sources in the lower limbs by ultrasonography. Pulmonary Embolism. Nakano T and Coldhaber SZ (eds), Springer-Verlag, Tokyo, p57-66, 1999
 
P.138 掲載の参考文献
1) Shimosegawa E, Hatazawa J, Inugami A, et al:Cerebral infarction within six hours of onset:Prediction of completed infarction with Technetium-99m-HMPAO SPECT. J Nucl Med 35:1097-1103 1994
PubMed
2) Ueda T, Sakaki S, Yuh WT, et al:Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 19:99-108 1999
 
3) Shishido F, Uemura K, Murakami M, et al:Cerebral uptake of 99mTc-bicisate in patients with cerebrovascular disease in comparison with CBF and CMRO2 measured by positron emission tomography. J Cereb Blood Flow Metab 14:S66-75 1994
PubMed
4) Shimosegawa E, Hatazawa J, Aizawa Y, et al:Technetium-99m-ECD brain SPECT in misery perfusion. J Nucl Med 38:791-796 1997
PubMed
5) Ogasawara K, Ogawa A, Konno H, et al:Combination of early and delayed SPECT imaging using technetium-99m ethyl cysteinate dimer immediately after local intra-arterial thrombolysis. Eur J Nucl Med 28:498-505 2001
PubMed
6) Yamauchi H, Fukuyama H, Nagahama Y, et al:Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET.J Neurol Neurosurg Psychiatry 61:18-25 1996
 
7) Kuroda S, Houkin K, Kamiyama H, et al:Longterm prognosis of medically treated patients with intemal carotid or middle cerebral artery occlusion:can acetazolamide test predict it? Stroke 32:2110-2116 2001
PubMed
8) Hayashi T, Suzuki A, Hatazawa J, et al:Cerebral circulation and metabolism in the acute stage of subarachnoid hemorrhage. J Neurosurg 93:1014-1018 2000
PubMed
9) Hatazawa J, Iida H, Shimosegawa E, et al:Regional cerebral blood flow measurement with iodine-123-IMP autoradiography:normal values, reproducibility and sensitivety to hypoperfusion. J Nucl Med 38:1102-1108 1997
 
10) Uemura K, Shishido F, Higano S, et al:Positron emision tomography in patients with a primary intracerebral hematoma Acta Radiolo (suppl) 369:426-428 1987
 
P.139 掲載の参考文献
11) Kuwabara Y, Ichiya Y, Sasaki M, et al:Response to hypercapnia in moyarnoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 28:701-707 1997
PubMed
12) Meguro K, Hatazawa J, Yamaguchi T, et al:Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 28:378-383 1990
PubMed
13) Yao H, Sadoshima S, Ibayashi S, et al:Leukoaraiosis and dementia in hypertensive patients. Stroke 23:1673-1677 1992
PubMed
14) Hatazawa J, Shimosegawa E, Satoh T, et al:Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. Stroke 28:1944-1947 1997
PubMed
15) Shimosegawa E, Kanno I, Hatazawa J, et al:Photic stimulation study of changing arterial partial pressure level of carbon dioxide. J Cerb Blood Flow Metab 15:111-114 1995
 
16) Ito H, Takahashi K, Hatazawa J, et al:Changes in human regional cerebral blood flow and cerebral blood volume during visual stimulation measured by positron emission tomography. J Cereb Blood Flow Metab 21:608-612 2001
PubMed
17) Silvestrini M, Cupini LM, Placidi F, et al:Bilateral hemispheric activation in the early recovery of motor function after stroke. Stroke 29:1305-1310 1998
PubMed

第5章 脳血管障害の新しい治療法

P.148 掲載の参考文献
1) Stroke Unit Trialists' Collaboration:Collaborative systematic review of the randomized trials of organized inpatient (stroke care) care after stroke. BMJ 314:1151-1159, 1997
PubMed
2) 峰松一夫:脳卒中救急医療システムと stroke care unit のあり方.ブレインアタック-超急性期の脳卒中診療-, 藤井清孝, 岡田靖編集, 中山書店, 東京, pp341-346, 1999
 
3) Krieger D, Hacke W:The intensive care of the stroke patients. In Stroke, pathophysiology, diagnosis, and management, third edition, ed by Barnett HJM, Mohr JP, Stein MB, et al, Churchill livingstone, New York, pp 1133-1154, 1998
 
4) Alberts MJ:Treatment of acute ischemic stroke. J Cerebrovasc Dis 10 (suppl 1):10-17, 2001
 
5) American Heart Association:The era of reperfusion; Acute stroke. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care; International consensus on science. Circulation 102 (suppl. I):I204-I216, 2000
 
6) Bock BF:Response system for patients presenting with acute stroke. In Proceedings of a National Symposium on Rapid identification and Treatment of Acute Stroke, ed by Marler JR, Jones PW, Emr M, National Institute of Neurological Disorders and Stroke, National Institute of Health, NIH Publication, No. 97-4239, Bethesda, pp 55-56, 1997
 
7) Adams HP Jr, Brott TG, Crowell RM, et al:Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:1901-1914, 1994
PubMed
8) Adams HP Jr, Brott TG, Furlan AJ, et al:Guidelines for thrombolytic therapy for acute stroke:A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 27:1711-1718, 1996
 
P.149 掲載の参考文献
9) Broderick JP:Guidelines for medical care and treatment of blood pressure in patients with acute stroke. In Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke, ed by Marler JR, Jones PW, Emr M, National Institute of Neurological Disorders and Stroke, National Institute of Health, NIH Publication, No. 97-4239, Bethesda, 63-68, 1997
 
10) Chen HJ, Lee TC, Wei CP:Treatment of cerebellar infarction by decompressive suboccipital craniectomy. Stroke 23:957-961, 1992
PubMed
11) Schwab S, Steiner T, Aschoff A, et al:Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 29:1888-1893, 1998
PubMed
12) Schwab S, Schwarz S, Spranger M, et al:Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29:2461-2466, 1998
PubMed
13) Price TR:Progressing ischemic stroke. In Stroke, pathophysiology, diagnosis, and management, vol 2, ed by Barnett HJM, Mohr JP, Stein MB, et al, Churchill Livingstone, New York, pp1059-1068, 1986
 
14) Cerebral Embolism Task Force:Cardiogenic brain embolism. Arch Neurol 43:71-84, 1986
PubMed
15) Parnham M, Sies H:Ebselen:prospective therapy for cerebral ischemia, Exp Opin Infest Drugs 9:1-13, 2000
 
16) Yamaguchi T, Sano K, Takakura K, et al:Ebselen in acute ischemic stroke, Stroke 29:12-17, 1998
PubMed
17) Ogawa A, Yoshimoto T, Kikuchi H, et al:Ebselen in acute middle cerebral artery occlusion:A placebo-controlled, double-blind clinical trial. Cerebrovasc Dis 9:112-118, 1999
PubMed
18) Matsui T, Mori T, et al:Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I:J Cereb Blood Flow Metab 22:711-22, 2002
 
19) Tateishi N, Mori T, et al:Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II:J Cereb Blood Flow Metab 22:723-34, 2002 (永沼雅基, 橋本洋一郎, 松浦 豊, 寺崎修司)
 
P.155 掲載の参考文献
1) National Institute of Neurological Disorder and Stroke early rt-PA Stroke Study Group:tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
 
2) Furlan A, Higashida R, Wechsler L, et al:Intra-arterial prourokinase for acute ischemic stroke. JAMA 282:2003-2011, 1999
PubMed
3) Minematsu K, Yamaguchi T, et al:'Spectacular shrinking deficit' ;Rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 42:157, 1992
 
4) Donnan GA, Davis SM, Chambers BR, et al:Streptokinase for acute ischemic stroke with relation to time of admministration. JAMA 276:961-966, 1996
 
5) Hommel M, Boissel JP, Cornu C, et al:Terminationof trial of streptokinase in severe acute ischaemic stroke. Lancet 345:57, 1994
 
6) Multicenter Acute Stroke Trial-ltaly (MAST-I) Group:Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 346:1509-1514, 1995
 
7) Hacke W, Kaste M, Fieschi C, et al:Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemisphric stroke. The Europian Cooperative Acute Stroke Study (ECASS):JAMA 274:1017-1025, 1995
 
8) Hacke W, Kaste M, Fieschi C, et al:Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II) . Lancet 352:1245-1251, 1998
 
9) Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study:a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019-26, 1999
PubMed
10) Adams HP, Brott TG, Furlan AJ, et al:Guidelines for thrombolytic therapy for acute stroke; A supplement to the guidelines for management of patients with acute ischemic stroke:A statement for health care professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 27:1711-1718, 1996
 
11) Yamaguchi T, Hayakawa T, Kikuchi H, et al:Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-272, 1993
 
12) 山口武典:脳梗塞急性期医療の実態に関する研究. 平成12年度厚生科学研究費補助金による健康科学総合研究事業研究報告書.pp.29-30, 国立循環器病センター, 大阪, 2001
 
13) Levy DE, Brott TG, Haley EC, et al:Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25:291-297, 1994
PubMed
14) Moulin T, Cattin E Crepin-Leblond T, et al:Early CT signs in acute middle cerebral artery infarction:predictive value for subsequent infarct locations and outcome. Neurology 47:366-375, 1996
 
P.160 掲載の参考文献
1) Breakfield XO:Gene delivery into the brain using virus vectors. Nature Genet 3:187, 1993
 
2) Culotta E:New startups move in as gene therapy goes commercial. Science 260:914, 1993
PubMed
3) Heistad DD and Faraci FM:Gene therapy for cerebral vascular disease. Stroke 27:1688, 1996
PubMed
4) Walsh C and Cepko CL:Clonally related cortical cells show several migration patterns. Science 241:1342, 1988
PubMed
5) Danko I, Fritz JD, Latendresse JS:Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum Mol Genet 2:2055, 1993
PubMed
6) Ono T, Fujino Y, Tsuchiya T, et al:Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci Lett 117:259, 1990
PubMed
7) Abe K, Aoki M, Kawagoe J, et al:Ischemic delayed neuronal death:A mitochondrial hypothesis. Stroke 26:1478, 1995
 
P.161 掲載の参考文献
8) Abe K, Araki T, Kogure K:Recovery from edema and of protein synthesis differs between in the cortex alld caudate following transient focal cerebral ischemia in rats J Neurochem 51:1470, 1988
 
9) Betz AL, Yang G-Y, Davidson BL:Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metabol 15:547, 1995
 
10) Abe K, Hayashi T, and Itoyama Y:Amelioration of brain edema by topical application of GDNF in reperfused rat brain. Neurosci. Lett. 231:37-40, 1997
PubMed
11) Kitagawa H, Hayashi T, Mitsumoto Y, Koga N, Itoyama Y, and Abe K.:Reduction of ischemic brain injury by topical application of GDNF after permanent MCAO in rats. Stroke 29:1417-1422, 1998
PubMed
12) Kitagawa H, Sasaki C, Sakai K, Mori A, Mitsumoto Y, Fukuchi Y, Setoguchi Y, and Abe K.:Adenovirus-mediated gene transfer of GDNF prevents ischemic brain injury after transient MCA occlusion in rats. J. Cereb. Blood Flow Metabol. (2000) in press
 
13) Linnik MD, Zahos P, Geschwind MD, et al:Expression of bcl-2 from a defective herpes simplex virus-1vector limits neuronal death in focal cerebral ischemia. Stroke 26:1670-1675, 1995
 
14) Ooboshi H, Welsh MJ, Rios CD, et al:Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ. Res. 77:7-16, 1995
PubMed
P.167 掲載の参考文献
1) Zubkov YN, Nikiforov BM, Shustin UA:Balloon catheter technique for dilatation of constricted cerebral arteries after aneurismal SAH. Acta Neurochir 70:65-79, 1984
 
2) Bejjani GK, Bank WO, Olan WJ, et al:The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42:979-987, 1998
PubMed
P.168 掲載の参考文献
3) Elliott JP, Newell DW, Lam DJ, et al:Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurismal subarachnoid hemorrhage. J Neurosurg 88:277-284, 1998
 
4) Eskridge JM, McAuliffe W, Song JK, et al:Balloon angioplasty for the treatment of vasospasm:results of first 50 cases. Neurosurgery 42:510-517, 1998
PubMed
5) Eskridge JM, Song JK, Elliott JP, et al:Balloon angioplasty of the A1 segment of the anterior cerebral artery narrowed by vasospasm. J Neurosurg 91:153-156, 1999
PubMed
6) Wanke I, Dorfler A, Dietrich U, et al:Combined endovascular therapy of ruptured aneurysms and cerebral vasospasm. Neuroradiology 42:926-929, 2000
PubMed
7) Johnston SC:Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke 31:111-117, 2000
PubMed
8) Kaku Y, Yonekawa Y, Tsukahara T, et al:Superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77:842-847, 1992
PubMed
9) Mathis JM, Jensen ME, Dion JE:Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 39:90-98, 1997
PubMed
10) Polin RS, Hansen CA, German P, et al:Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 42:1256-1267, 1998
PubMed
11) Rosenwasser RH, Armonda RA, Thomas JE, et al:Therapeutic modalities for the management of cerebral vasospasm:timing of endovascular options. Neurosurgery 44:975-980, 1999
PubMed
12) Newell DW, Eskridge JM, Mayberg M, et al:Endovascular treatment of intracranial aneurysms and cerebral vasospasm. Clin Neurosurg 39:348-360, 1992
 
13) Muizelaar JP, Zwienenberg M, Rudisill NA, et al:The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage:a pilot study. J Neurosurg 91:51-58, 1999
PubMed
14) 杉生憲志, 西田あゆみ, 勝間田篤ほか:脳血管性疾患に対する cerebral parenchymography の有用性.脳神経外科 30:379-388, 2002
 
15) Theron J, Nelson M, Alachkar F, et al:Dynamic digitized cerebral parenchymography. Neuroradiology 34:361-364, 1992
PubMed
16) Polin RS, Coenen VC, Hansen CA, et al:Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurismal subarachnoid hemorhhage. J Neurosurg 92:284-290, 2000
 
P.175 掲載の参考文献
1) Weir B:The pathophysiology of cerebral vasospasm. Br J Neurosurg 9:375-390, 1995
PubMed
2) Weir B, Macdonald RL, Stoodley M:Etiology of cerebral vasospasm. Acta Neurochir Suppl 72:27-46, 1999
PubMed
3) Kavdia M, Tsoukias NM, Popel AS:Model of nitric oxide diffusion in an arteriole:impact of hemoglobin-based blood substitutes. Am J Physiol Heart Circ Physiol 282:H2245-53, 2002
 
4) Eguchi D, Weiler D, Alam J, et al:Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction. J Cereb Blood Flow Metab 21:1215-1222, 2001
PubMed
5) Ogihara K, Aoki K, Zubkov AY et al:Oxyhemoglobin produces apoptosis and necrosis in cultured smooth muscle cells. Brain Res 889:89-97, 2001
PubMed
6) Zhang ZD, Yamini B, Komuro T, et al:Delayed clot removal and experimental vasospasm. Acta Neurochir Suppl 77:33-35, 2001
PubMed
7) Seifert V, Loffler BM, Zimmermann M, et al:Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62, 1995
PubMed
8) Ogihara K, Barnanke DH, Zubkov AY, et al:Effect of endothelin receptor antagonists on non-muscle matrix compaction in a cell culture vasospasm model. Neurol Res 22:209-214, 2000
 
9) Matsui T, Asano T:Protein kinase C and vasospasm. J Neurosurg 85:1197-1198, 1996
PubMed
10) Macdonald RL, Weir BK:Areview of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991
 
P.176 掲載の参考文献
11) Onoda K, Ono S, Ogihara K, et al:Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846-852, 1996
 
12) Stoodley M, Weihl CC, Zhang ZD, et al:Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 46:1193-1202, 2000
PubMed
13) Wolf EW, Banerjee A, Soble-Smith J, et al:Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg 89:279-288, 1998
PubMed
14) Sercombe R, Dinh YR, Gomis P:Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 88:227-249, 2002
PubMed
15) Fassbender K, Hodapp B, Rossol S, et al:Inflammatory cytokines in subarachnoid haemorrhage:association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 70:534-537, 2001
PubMed
16) Ono S, Date I, Onoda K, et al:Decoy administration of NF-kappaB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther 9:1003-1011, 1998
PubMed
17) Aihara Y, Kasuya H, Onda H, et al:Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32:212-217, 2001
PubMed
18) Onda H, Kasuya H, Takakura K, et al:Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279-1288, 1999
 
19) Takuwa Y, Matsui T, Abe Y, et al:Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 13:409-415, 1993
PubMed
20) Takenaka K, Yamada H, Sakai N, et al:Intracellular Ca?+ changes in cultured vascular smooth muscle cells by treatment with various spasmogens. Neurol Res 13:168-172, 1991
 
21) Zhang J:Oxyhemoglobin and intracellular calcium. J Neurosurg 93:370-371, 2000
PubMed
22) Uehata M, Ishizaki T, Satoh H, et al:Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994, 1997
PubMed
23) Sato M, Tani E, Fujikawa H, et al:Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195-200, 2000
PubMed
24) 鈴木善男, 渋谷正人, 高安正和ほか:脳血管攣縮, 中外医学社, 東京, pp53-58, 1999
 
25) Ono S, Komuro T, Macdonald RL:Adenovirus-mediated heme oxygenase-1 gene transfection prevents hemoglobin-induced contraction of rat basilar artery. Acta Neurochir Suppl 77:93-96, 2001
PubMed
26) Khurana VG, Smith LA, Weiler DA, et al:Adenovims-mediated gene transfer to human cerebral arteries. J Cereb Blood Flow Metab 20:1360-1371, 2000
PubMed
27) Muhonen MG, Ooboshi H, Welsh MJ, et al:Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 28:822-828, 1997
PubMed
28) Toyoda K, Faraci FM, Watanabe Y, et al:Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res 87:818-824, 2000
PubMed
29) Yamamoto Y, Smith RR, Bernanke DH:Accelerated nonmuscle contraction after subarachnoid hemorrhage:culture and characterization of myofibroblasts from human cerebral arteries in vasospasm. Neurosurgery 30:337-345, 1992
PubMed
30) Yumamoto Y, Bernanke DH, Smith RR:Accelerated non-muscle contraction after subarachnoid hemorrhage:cerebrospinal fluid testing in a culture model. Neurosurgery 27:921-928, 1990
 
31) Ono S, Komuro T, Macdonald RL:Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 96:1094-1102, 2002
PubMed
P.181 掲載の参考文献
1) Karibe H, Chen J, Zarow GJ, et al:Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J Neurosurg 80:112-119, 1994
PubMed
2) Yanamoto H, Nagata I, Niitsu Y, et al:Prolonged mild hypothermia therapy protects the brain against permanent focal ischemia. Stroke 32:232-239, 2001
PubMed
3) Corbett D, Nurse S, Colboume F:Hypothermic neuroprotection:Aglobal ischemia study using 18-to 20-month-old gerbils. Stroke 28:2238-2243, 1997
 
4) 成冨博章:急性期脳梗塞に対する低体温療法.神経内科 52:185-191, 2000
 
5) The Hypothermia After Cardiac Arrest Study group:Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549-556, 2002
 
6) Bernard SA, Gray TW, Buist MD, et al:Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557-563, 2002
PubMed
P.182 掲載の参考文献
7) Schwab S, Schwarz S, Spranger M, et al:Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29:2461-2466, 1998
PubMed
8) Schwab S, Georgiadis D, Berrouschot J, et al:Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 32:2033-2035, 2001
PubMed
9) Kriegler DW, DeGeorgia MA, Abou-Chebl A, et al:Cooling for acute ischemic brain damage (COOL AID) . An open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32:1847-1854, 2001
 
10) Takasato Y, Masaoka H, Wakimoto H, et al:Combined therapy of local intraarterial thrombolysis and brain hypothermia for acute occlusion of the cerebral main trunk arteries. Hayashi N ed:Brain Hypothermia, Springer-Verlag, Tokyo, p187-193, 2000
 
11) Naritomi H, Nagatsuka K, Miyashita K, et al:The importance of thermal changes in the pathophysiology of stroke:post-stroke fever and hypothermia therapy. Kikuchi H ed:Strategic Medical Science Against Brain Attack, Springer-Verlag, Tokyo, P171-185, 2002
 
12) Sacco RL, DeRosa JT, Haley JrEC, et al:Glycine antagonist in neuroprotection for patients with acute stroke. GAIN Americas:A randomized controlled trial. JAMA 285:1719-1728, 2001
 
P.190 掲載の参考文献
1) Lougheed WM, Sweet WH, White JC, et al:The use of hypothermia in surgical treatment of cerebral vascular lesions. J Neurosurg 12:240-255, 1955
PubMed
2) Michenfelder JD, Terry HR, Dew EF, et al:Induced hypothermia:Physiological effects, indications and techniques. Surg Clin North Am 45:889-898, 1965
 
3) Ausman JI, Malik GM, Tomecek FJ, et al:Hypothermic circulatory arrest and the management of giant and large cerebral aneurysms. Surg Neurol 40:289-298, 1993
PubMed
4) Baumgartner WA, Silverberg GD, Ream AK, et al:Reappraisal of cardiopulmonary bypass with deep hypothermia and circulatory arrest for complex neurosurgical operations. Surgery 94:242-24, 1983
PubMed
5) Spetzler RE Hadly MN, Rigamonti D, et al:Aneurysms of the basilar artery treated with circulatory arrest, hypothermia, and barbiturate cerebral protection. J Neurosurg 68:868-879, 1988
 
6) MacDonald JL, Cleland AG, Mayer RL, et al:Extracorporeal circuit design considerations for giant intracranial aneurysm repair. Perfusion 12:193-196, 1997
PubMed
7) Mesana T, Collart F, Cuas T, et al:Centrifugal pumps and heparin-coated circuits in surgical treatment of giant cerebral aneurysms. Artif Organs 24:431-436, 2000
 
8) Grady RE, Oliver JrWC, Abel MD, et al:Aprotinin and deep hypothermic cardiopulmonary bypass with or without circulatory arrest for craniotomy. J Neurosurg Anesthesiol 14:137-140, 2002
PubMed
9) 大滝雅文, 南田善弘, 上出廷治ほか:Percutaneous cardiopulmonary support system (PCPS) を用いた超低体温下, 血栓化巨大脳動脈瘤の手術.脳卒中外科 27:392-399, 1999
 
10) Solomon RA:Principles of aneurysm surgery:Cerebral ischemic protection, hypothermia, and circulatory arrest. Clin Neurosurg 41:351-363, 1994
PubMed
11) Steinberg GK, Grant G, Yoon EJ:Deliberate hypo-thermia, An (壮ews RI eds:Intraoperative Neuro-protection, Williams &Wilkins, Baltimore, p65-84, 1996
 
P.196 掲載の参考文献
1) Yasargil MG:Diagnosis and indications for operatins in cerebrovascular occlusive disease. In Microsurgery applied to neurosurgery. Yasargil MY ed. Georg Thieme Verlag, Stuttgart, pp95-119, 1969
 
2) Hallett JW Jr., Cherry KJ, Pairolero PC, et al:Brachiocephalic reconstruction:Operative techniques. In Occlusive Cerebrovascular Diseases. Sundt TM Jr. ed. WB Asunders Company, Philaderphia, London, Toronto, Montreal, Sydney, Tokyo, pp369-384, 1987
 
3) Okada Y, Shima T, Nishida M, et al:Retroauricular subcutaneous Dacron tunnel for extracranial-intracranial autologous vein bypass graft. J Neurosurg 81:800-801, 1994
 
4) Okada Y, Shima T, Nishida M, et al:Traumatic dissection of the common carotid artery after blunt injury to the neck Surg Neurol 51:513-520, 1999
 
5) 宝金清博:橈骨動脈 long graft bypass. 脳血行再建術 上山博康 監修 中外医学社 pp103-116, 2000
 
6) Stanley JC, Lindenauer SM, Graham LM, et al:Biologic and synthetic vascular grafts. Vascular Surgery. A comprehensive Review. Moore WS ed. WB Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, pp275-294, 1991
 
7) 松本博志, 宮脇富士夫:人工血管.ME人工臓器, 新外科学体系
 
8) 和田達雄監修, 中山書店, 東京, pp213-234, 1992
 
P.200 掲載の参考文献
1) European Carotid Surgery:Trialists' Collaborative Group:MRC European Carotid Surgery Trial:interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337:1235-1243, 1991
 
2) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study:Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428, 1995
PubMed
3) North American Symptomatic Carotid Endarterectomy Trial Collaborators:Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Medicine 325:445-453, 1991
 
4) 岡田芳和:頸動脈血栓内膜切除術-シャントシステムを用いて-. 脳外 29:497-508, 2001
 
5) Shima T, Okada Y, Nishida M, et al:A newly developed shunt system for carotid surgery:T-shaped silicone shunt tubes and clamping devices:technical note. Neurosurgery 42:1182-1185, 1998
PubMed
6) 山根冠児, 島 健, 岡田芳和ほか:近赤外光による脳虚血の評価-頸動脈血栓内膜摘除術中モニタリングから. 脳外 22:947-953, 1994
 
7) Davies MJ, Murrell GC, Cronin KD, et al:Carotid endarterectomy under cervical plexus block-aprospective clinical audit. Anaesth Intensive Care 18:219-223, 1990
 
8) 岡田芳和, 島 健:Carotid endarterectomy の術中モニタリング (岡田芳和, 島 健編) 脳神経外科 手術術中モニタリング. 現代医療社, pp3-37, 1995
 
9) Trojaborg W, Boysen G:Relation between EEG, regional cerebral blood flow and internal carotid artery pressure during carotid endarterectomy. Electroencephalogr Clin Neurophysiol 34:61-69, 1973
PubMed
10) Ferguson GG:Carotid endarterectomy. To shunt or not to shunt? Arch Neurol 43:615-617, 1986
 
11) Archie JP, Jr., Feldtman RW:Determinants of cerebral perfusion pressure during carotid endarterectomy. Arch Surg 117:319-322, 1982
PubMed
12) Hays RJ, Levinson SA, Wylie EJ:Intraoperative measurement of carotid back pressure as a guide to operative management for carotid endarterectomy. Surgery 72:953-960, 1972
PubMed
13) Moore WS, Yee JM, Hall AD:Collateral cerebral blood pressure. An index of tolerance to temporary carotid occlusion. Arch Surg 106:521-523, 1973
PubMed
14) Hughes RK, Bustos M, Byrne JP, Jr.:Internal carotid artery pressures. A guide for use of shunt during carotid repair. Arch Surg 109:494-495, 1974
PubMed
15) Rosenthal D, Stanton PE, Jr., Lamis PA:Carotid endarterectomy. The unreliability of intraoperative monitoring in patients having had stroke or reversible ischemic neurologic deficit. Arch Surg 116:1569-1575, 1981
PubMed
16) 豊田章宏, 島 健, 西田正博ほか:頸部頸動脈分岐部の放射線学的検討-邦人とハンガリー人の比較-脳神経 49:633-637, 1997
 
P.204 掲載の参考文献
1) The EC/IC Bypass Group:Failure of extracranial/intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313:1191-1200, 1985
 
2) Houkin K, Kamiyama H, Abe H, et al:Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 27:1342-1346, 1996
PubMed
3) Karasawa J, Kikuchi H, Furuse S, et al:Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 49:679-688, 1978
PubMed
4) Okada Y, Shima T, Nishida M, et al:Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease. Cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 29:625-630, 1998
PubMed
5) Klijn CJM, Kappelle LJ, Tulleken CAF, et al:Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke 28:2084-2093, 1997
 
6) Schmiedeck P, Piepgras A, Leinsinger G:Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. J Neurosurg 81:236-244, 1994
 
7) Kamiyama H, Takahashi A, Houkin K, et al:Visualization of the ostium of an arteriotomy in bypass surgery. Neurosurgery 33:1109-1110, 1993
PubMed
8) Ojemann RG, Crowell RM:Surgical management of cerebral vascular disease. Williams &Wilkins, Baltimore, p71-92, 1983
 
9) Okada Y, Shima T, Nishida M, et al:Retroauricular subcutaneous Dacron tunnel for extracranial-intracranial autologous vein bypass graft. J Neurosurg 81:800-802, 1994
 
P.208 掲載の参考文献
1) Aoyama H, Shirato H, Nishioka T, et al:Treatment Outcome of Single or Hypofractionated Single-isocentric Stereotactic Irradiation (STI) using a Linear Accelerator for Intracranial Arteriovenous Malformation. Radiother Oncol 59:323-328, 2001
 
P.209 掲載の参考文献
2) Miyawaki L, Dowd C, Wara W, et al:Five year results of LINAC radiosurgery for arteriovenous malformations:outcome for large AVMS. Int J Radiat Oncol Biol Phys 44:1089-106, 1999
PubMed
3) Touboul E, Halabi AA, Buffat L, et al:Single-Fraction Stereotaction Radiotherapy:A Dose-Response Analysis Of Arteriovenous Malfomation Obliteration. Int. J. Radiat. Oncol. Biol. Phys. 41:855-861, 1998
 
4) Schlienger M, Atlan D, Lefkopoulos D, et al:Linac radiosurgery for cerebral arteriovenous malformation:results in 169 patients. Int J Radiat Oncol Biol Phys 46:1135-1142, 2000
PubMed
5) Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD:A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 36:873-879, 1996
PubMed
6) Flickinger JC, Kondziolka D, Lunsford LD, et al:Development of a model to predict permanent symptomatic postradiosurgery. Int. J. Radiat. Oncol, Biol. Phys. 46:1143-1148, 2000
 
7) Kjellberg RN, Hanamura T, Davis KR, et al:Braggpeak proton-beam therapy for arteriovenous malformation of the brain. N Eng J Med 309:269-274, 1983
 
8) Friedman WA, Blatt DL, Bova FJ, Buatti JM, Mendenhall WM, Kubilis PS:The risk of hemorrhage after radiosurgery for arteriovenous malformations. J Neurosurg 84 (6):912-9, 1996
PubMed
9) Kihlstrom L, Guo WY, Karlsson B, Lindquist C, Lindqvist M:Magnetic resonance imaging of obliterated alteriovenous malformations up to 23 years after radiosurgery. J Neurosurg 86:589-593, 1997
PubMed
10) Mizoi K, Jokura H, Yoshimoto T, et al:Multimodality treatment for large and critically located arteriovenous malformations. Neurol Med Chir (Tokyo) 38 Suppl:186-92, 1998
 
11) Laing RW, Childs J, Brada M:Failure of conventionally fractionated radiotherapy to decrease the risk of hemorrhage in inoperable arteriovenous malformations. Neurosurgery 30:872-875, 1992
PubMed
12) Shirato H, Sakamoto T, Takeichi N, et al:Fractionated stereotactic radiotherapy for vestibular schwannoma (VS):comparison between cystic-type and solid-type VS. Int J Radiat Oncol Biol Phys. 48:1395-401, 2000
PubMed
13) Brenner DJ, Martel MK, Hall EJ:Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain. Int. J. Radiat. Oncol. Biol. Phys. 21:819-824, 2000
 
14) Aoyama H, Shirato H, et al:Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys 50:821-827, 2001
PubMed
15) Bednarz G, Downes B, Wener-Wasik M, et al:Combining stereotactic angiography and 3D time-of-flight magnetic resonance angiography in treatment planning for arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 46:1149-1154, 2000
 
16) Niemierko A and Goitein M:Modeling of normal tissue response to radiation:the critical volume model. Int J Radiat Oncol Biol Phys 25:135-145, 1992
 
17) Flickinger JC:An integrated logistic formula for prediction of complications from radiosurgery. Int JRadiat Oncol Biol Phys 17:879-885, 1989
PubMed
P.214 掲載の参考文献
1) Steiner L, Leksell L, Greitz T, et al:Stereotactic radiosurgery forcerebral arteriovemous malformations. Report of a case. Acta Chir Scand 138:459-464, 1972
PubMed
2) Altschuler EM, Lunsford LD, Coffey RJ, et al:Gamma knife radiosurgery for intracranial artriovenous malformations in childhood and adolescence Pediar Neurosci 15:53-61, 1989
 
3) Forster DE:The Sheffield "gamma knife" experience:Results of arteriovenous malformation radiosurgery in 507 patient. In Stereotactic Radiosurgery Update, lansford LD (ed), Chapter 17:pp113-115, Elsevier Science, New York, 1992
 
4) Lunsford LD, Kondziolka D, Flinckinger JC, et al:Stereotactic radiosurgery forarteriovenous maiformations of the brain. J Neurosurgery 75:512-524, 1991
 
5) Pollock BE, Lunsford LD, Kondziolka D, et al:Patient outcomes after stereotactic radiosurgery for "operable" arteriovenous malformations. Neurosurgery 5:1-8, 1994
 
6) Steiner L:Radiosurgery in intracranial tumors and arteriovenous malformations in chirdren. In:Tumor of the Cerebral Nervous System in infancy and Childhood, Voth D, Gutjahr P, Langmaid C (eds), pp315-324, Springer-Verlag, Berlin, Heidelberg, 1982
 
7) Steiner L:Radiosurgery in cerebral arteriovenous malformations. In:Cerebrovascular Surgery, Fein JM, Flamm ED (eds), VOl. 4:pp1161-1251, Springer-Verlag, New YOrk, 1985
 
8) Steiner L, Lindquist C, Steiner M:Radiosurgery with focused gamma-beam irradiation children. In:Cerebral Vascular Diseases in Children and Adolescence, Edwards M, Hoffman H (eds), pp367-388, Williams &Wilkins, 1989
 
9) Steiner L, Lindquist C, Steiner M:Radiosurgery. In:Advances and Technical Standards in Neurosurgery, Symon L (ed), Vol 19:pp40-57, Springer-Verlag, Wien, New York, 1992
 
10) Schneider BF, Eberhard DA, Steiner LE:Histopathology of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg. 87 (3):352-357,1997
PubMed
11) Hillman J:Population-based analysis of arteriovenous malformation treatment. J Neurosurg. 95 (4):633-637, 2001
PubMed
12) Karlsson B, Lax I, Soderman M:Factors influencing the risk for complications following Gamma Knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol. 43 (3):275-280, 1997
PubMed
13) Vymazal J, Liscak R, Novotny J Jr, Janouskova L, Vladyka V:The role of Gamma Knife radiosurgery in arteriovenous malformation with aneurysms. Stereotact Funct Neurosurg. 72 (Suppl 1):175-184, 1999
 
14) Flickinger JC, Kondziolka D, Pollock BE, Maitz AH:Lunsford LD. Complications from arteriovenous malformation radiosurgery:multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys. 38 (3):485-490, 1997
PubMed
15) Flickinger JC, Kondziolka D, Lunsford LD, Kassam A, Phuong LK, Liscak R, Pollock B:Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys. 46 (5):1143-1148, 2000
 
16) Maitz AH, Niranjan A, Jungreis CA, Kondziolka D, Flickinger JC, Lunsford LD:Tube angulation improves angiographic targeting of arteriovenous malformations during stereotactic radiosurgery. Comput Aided Surg. 6 (4):225-229, 2001
PubMed
17) Bednarz G, Downes B, Werner-Wasik M, Rosenwasser RH:Combining stereotactic angiography and 3D time-of-flight magnetic resonance angiography in treatment planning for arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys. 46 (5):1149-1154, 2000
PubMed
18) Lindqvist M, Karlsson B, Guo WY, Kihlstrom L, Lippitz B, Yamamoto M:Angiographic long-term follow up data for arteriovenous malformations previously proven to be obliterated after gamma knife radiosurgery. Neurosurgery. 46 (4):803-8; discussion 809-810, 2000
 
19) Lunsford LD, Kondziolka D, Maitz A, Flickinger JC:Black holes, white dwarfs and supernovas:imaging after radiosurgery. Stereotact Funct Neurosurg. 70 (Suppl 1):2-10, Nervenarzt. 69 (4):287-95, Review. German. 1998
 
20) Chang JH, Chang JW, Park YG, Chung SS:Factors related to complete occlusion of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg. 93 (Suppl 3):96-101, 2000
 
21) Kihlstrom L, Guo WY, Karlsson B, Lindquist C, Lindqvist M:Magnetic resonance imaging of obliterated arteriovenous malformations up to 23 years after radiosurgery. J Neurosurg. 86 (4):589-593, 1997
PubMed
22) Soderman M, Rodesch G, Karlsson B, Lax I, Lasjaunias P:Gamma knife outcome models as a reference standard in the embolisation of cerebral arteriovenous malformations. Acta Neurochir (Wien) . 143 (8):801-10, 2001
PubMed
23) Pan DH, Guo WY, Chung WY, Shiau CY, Chang YC, Wang LW:Gamma knife radiosurgery as a single treatment modality for large cerebral arteriovenous malformations. J Neurosurg. 93 (Suppl 3):113-119, 2000
 
24) Pendl G, Unger E Papaefthymiou G, Eustacchio S:Staged radiosurgical treatment for large benign cerebral lesions. J Neurosurg. 93 (Suppl 3):107-12, 2000
 
25) Karlsson B, Lax I, Soderman M:Risk for hemorrhage during the 2-year latency period following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys. 49 (4):1045-1051, 2001 (中村克巳, 八代一孝, 藤元登四郎, 松本哲郎)
 

第6章 脳動脈瘤のトピックス

P.221 掲載の参考文献
1) Schievink WI, Schaid DJ, Michels VV, et al:Familial aneurysmal subarachnoid hemorrhage:a community-based study. J Neurosurg 83:426-429, 1995
PubMed
2) Ronkainen A, Hernesniemi J, Puranen M, et al:Familial intracranial aneurysms. Lancet 349:380-384, 1997
PubMed
3) Schievink WI:Genetics of intracranial aneurysms. Neurosurgery 40:651-662, 1997
PubMed
4) Schievink WI, Schaid DJ, Rogers HM, et al:On the inheritance of intracranial aneurysms. Stroke 25:2028-2037, 1994
PubMed
5) Onda H, Kasuya H, Yoneyama T, et al:Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet 69:804-819, 2001
PubMed
6) Ikari K, Onda H, Furushima K, et al:Establishment of an optimized set of 406 microsatellite markers covering the whole genome for the Japanese population. J Hum Genet 46:207-210, 2001
PubMed
7) Elston R, Bailey-Wilson J, Bonney G, et al:Sibpair linkage program (SIBPAL) in S. A. G. E., Statistical Analysis for Genetic Epidemiology, Release 3.1 (Case Western Reserve University, Cleveland, OH), 1997
 
8) Kruglyak L, Daly MJ, Reeve-Daly MP, et al:Parametric and nonparametric linkage analysis:aunified multipoint approach. Am J Hum Genet 58:1347-1363, 1996
PubMed
9) Lander E, Kruglyak L:Genetic dissection of complex traits:guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247, 1995
PubMed
10) Glynn L:Medial defects in the circle of Willis and their relation to aneurysm formation. Journal of Pathology Bacteriology 51:213-222, 1940
 
11) Carmichael R:Gross defects in the muscular and elastic coats of the larger cerebral arteries. Journal of Pathology Bacteriology 57:345-351, 1945
 
12) Stebens WE:Histopathology of cerebral aneurysms. Archives of neurology 8:272-285, 1963
 
13) Hashimoto N, Handa H, Hazama F:Experimentally induced cerebral aneurysms in rats. Surg Neurol 10:3-8, 1978
PubMed
14) Miskolczi L, Guterman LR, Flaherty JD, et al:Saccular aneurysm induction by elastase digestion of the arterial wall:a new animal model. Neurosurgery 43:595-600, 1998
PubMed
15) Peoples R, Franke Y, Wang YK, et al:A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome-deletion region at 7q11. 23. Am J Hum Genet 66:47-68, 1998
 
16) Curran ME, Atkinson DL, Ewart AK, et al:The elastin gene is disrupted by a translocation associating with supravalvular aortic stenosis. Cell 73:159-168, 1998
 
P.228 掲載の参考文献
1) Bendszus M, Koltzenburg M, Burger R, et al:Silent embolism in diagnostic cerebral angiography and neurointerventional procedures:a prospective study. Lancet 354:1594-1597, 1999
PubMed
2) Ishida F, Kawaguchi K, Mizuno M, et al:The accuracy and usefulness of 3D-DSA and 3D-CT angiography for cerebral aneurysms. Interv Neuroradiol 7 (suppl. 1):181-186, 2001
 
3) Schwartz RB, Tice HM, Hooten SM, et al:Evaluation of cerebral aneurysms with helical CT:correlation with conventional angiography and MR angiography. Radiology 192:717-722, 1994
 
4) 佐藤正憲, 遠藤雄司, 松本正人ら:Three-dimensional CT angiography による急性期破裂脳動脈瘤手術. 脳外誌 10:18-26, 2001
 
5) Alberico RA, Patel M, Casey S, et al:Evaluation of the circle of Willis with three-dimensional CT angiography in patients with suspected intracranial aneurysms. AJNR 16:1571-1578, 1995
PubMed
6) Hope JK, Wilson JL, Thomson FJ:Three-dimensional CT angiography in the detection and characterization of intracranial berry aneurysms. AJNR 17:439-445, 1996
PubMed
7) Nakajima Y, Yoshimine T, Yoshida H, et al:Computerized tomography angiography of ruptured cerebral aneurysms:factors affecting time to maximum contrast concentration. J Neurosurg 88:663-669, 1998
PubMed
8) Zouaoui A, Sahel M, Marro B, et al:Three-dimensional computed tomographic angiography in detection of cerebral aneurysms in acute subarachnoid hemorrhage. Neurosurgery 41:125-130, 1997
PubMed
9) Hashimoto H, Iida J, Hironaka Y, et al:Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms. J Neurosurg 92:278-283, 2000
 
10) Kato Y, Sano H, Katada K, et al:Clinical usefulness of 3-D CT endoscopic imaging of cerebral aneurysms. Neurol Res l 8:98-102, 1996
 
11) 佐藤透:3D-MRA・仮想血管内視鏡による脳動脈瘤の内腔診断. 脳外 10:518-524, 2001
 
12) Kato Y, Katada K, Hayakawa M, et al:Can 3D-CTA surpass DSA in diagnosis of cerebral aneurysm? Acta Neurochir (Wien) 143:245-250, 2001
PubMed
13) Murayama Y, Sakurama K, Satoh K, et al:dentification of the carotid artery dural ring by using three-dimensional computerized tomography angiography. Technical note. J Neurosurg 95:533-536, 2001
 
14) Le Roux PD, Elliott JP, Eskridge JM, et al:Risk and benefits of diagnostic angiography after aneurysm surgery:A retrospective analysis of 597 studies. Neurosurgery 42:1248-1255, 1998
PubMed
15) Debrun GM, Aletich VA, Kehrli P, et al:Aneurysm geometry:an important criterion in selecting patients for GDC. Neurol Med Chir (Tokyo) 38:1-20, 1998
PubMed
16) Parlea L, Fahrig R, Holdsworth DW, et al:An analysis of the geometry of saccular intracranial aneurysms. AJNR 20:1079-1089, 1999
PubMed
17) Regli L, Uske A, de Tribolet N:Endovascular coil placement compared with surgical clipping for treatment of unruptured middle cerebral artery aneurysm:a consecutive series. J Neurosurg:90:1025-1030, 1999
 
18) Ujiie H, Tachibana H, Hiramatsu O, et al:Effect of size and shape on hemodynamics of saccular aneurysm:a possible index for surgical treatment of intracranial aneurysm. Neurosurgery 45:119-129, 1999
PubMed
19) Baxter BW, Rosso D, Lownie SP:Double microcatheter technique for detachable coil treatment of large, wide-necked intracranial aneurysms. Am J Neuroradiol 19:1176-1178, 1998
 
20) Moret J, Cognard C, Weill A, et al:The "remodeling technique" in the treatment of wide-neck intracranial aneurysms. Angiographic results and clinical follow-up in 56 cases. Interv Neuroradiol 3:21-35, 1997
PubMed
21) Murao K, Taki W, Kawaguchi K, et al:Interventional radiologic technique for basilar bifurcation aneurysms. Techniquues in Neurosurgery 6:234-237, 2000
 
22) Cloft HJ, Joseph GJ, Tong FC, et al:Use of three-dimensional Guglielmi detachable coils in the treatment of wide-necked cerebral aneurysms. AJNR 21:1312-1314, 2000
PubMed
23) Choi IS, Chavali RV, Hirsch JA:Piecemeal technique in GDC treatment of wide-neck or elongated aneurysms. Interv Neuroradiol 5 (suppl. 1):61, 1999
 
24) Anzalone N, Righi C, Simionato F, et al:Three-dimensional time-of-flight MR angiography in the evaluation of intracranial aneurysms treated with GDCs. AJNR 21:746-752, 2000
PubMed
25) Klotzsch C, Bozzato A, Larnmers G, et al:Three-dimensional transcranial color-coded sonography of cerebral aneurysms. Stroke 30:2285-2290, 1999
 
P.235 掲載の参考文献
1) 山浦 晶, 吉本高志, 橋本信夫ほか:非外傷性頭蓋内解離性動脈病変の全国調査 (第1報) . 脳卒中の外科 26:79-86, 1998
Medical*Online
2) 山浦 晶, 吉本高志, 橋本信夫ほか:非外傷性頭蓋内解離性動脈病変の全国調査 (第2報) . 脳卒中の外科 26:87-95, 1998
Medical*Online
3) Yamaura A, Watanabe Y, Saeki N:Dissecting aneurysms of the intracranial vertebral artery. J Neurosurg 72:183-188, 1990
PubMed
4) Yamaura A, Ono J:Current diagnosis and treatment of intra-cranial dissecting aneurysms. Neurosurgery Quarterly 4:67-81, 1994
 
5) 山浦 晶, 小野純一, 久保田基夫:頭蓋内解離性動脈病変の研究-本邦例の分析と外国例との比較-Neurosurgeons 15:54-61, 1996
 
6) 小野純一, 山浦 晶:解離性動脈瘤の治療, 端 和夫, 上出廷治監修, 脳卒中臨床マニュアル, シュプリンガーフェアラーク東京, 東京, p261-273, 1998
 
7) Mizutani T, Aruga T, Kirino T, et al:Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms. Neurosurgery 36:905-913, 1995
PubMed
8) 小野純一, 平井伸治, 芹澤 徹ほか:椎骨脳底動脈系解離性動脈病変の転帰決定因子-再出血に影響を及ぼす因子の検討-. 脳外誌 11:265-270, 2002
 
9) 小野純一:椎骨動脈解離性動脈瘤の手術. 脳神経外科速報 12:199-208, 2002
 
10) Pozzati E, Andreoli A, Limoni P, et al:Dissecting aneurysms of the vertebrobasilar system:study of 16 cases. Surg Neurol 41:119-124, 1994
PubMed
11) Sano H, Kato Y, Okuma I, et al:Classification and treatment of vertebral dissecting aneurysm. Surg Neurol 48:598-605, 1997
PubMed
12) 水谷 徹, 三木啓全:PICA-involved type の解離性椎骨動脈瘤の治療選択. 脳卒中の外科 27:369-374, 1999
 
13) 上山博康:解離性脳動脈瘤, 山浦 晶編集, 脳動脈瘤の外科, III. Modified Technique, 三輪書店, 東京, p325-336, 1995
 
14) 園部 真:血管内手術, 生塩之敬, 山浦 晶編集, Neurosurgery Headline 3, 後頭蓋窩病変II, 血管性病変, VII.血管内手術, 三輪書店, 東京, p128-138, 1998
 
15) 波多野武人, 塚原徹也, 川上 理ほか:ステント留置が有効であった頭蓋内椎骨脳底動脈解離性閉塞病変の2例. 脳卒中の外科 29:364-368, 2001
 
P.242 掲載の参考文献
1) Ohmoto T, Nagao S, Mino S, et al:Monitoring of cortical blood flow during temporary arterial occlusion in aneurysm surgery by the thermal diffusion method. Neurosurgery 28:49-54, 1991
PubMed
2) Ogawa A, Sato H, Sakurai Y, et al:Limitation of temporary vascular occlusion during aneurysm surgery. Study by intraoperative monitoring of cortical blood flow. Surg Neurol 36:453-457, 1991
PubMed
3) Vajkoczy P, Roth H, Hom P, et al:Continuous monitoring of regional cerebral blood flow:experimental and clinical validation of a novel thermal diffusion microprobe. J Neurosurg 93:265-274, 2000
 
4) Thome C, Vajkoczy P, Hom P, et al:Continuous monitoring of regional cerebral blood flow during temporary arterial occlusion in aneurysm surgery. J Neurosurg 95:402-411, 2001
 
5) Doppenberg EM, Watson JC, Broaddus WC, et al:Intraoperative monitoring of substrate delivery during aneurysm and hematoma surgery:initial experience in 16 patients. J Neurosurg 87:809-816, 1997
PubMed
6) Hutchinson PJ, O'Connell MT, Al-Rawi PG, et al:Clinical cerebral microdialysis:a methodological study. J Neurosurg 93:37-43, 2000
PubMed
7) Kett-White R, Hutchinson PJ, Al-Rawi PG, et al:Cerebral oxygen and microdialysis monitoring during aneurysm surgery:effects of blood pressure, cerebrospinal fluid drainage, and temporary clipping on infarction. J Neurosurg 96:1013-1019, 2002
PubMed
8) Symon L, Momma F, Murota T:Assessment of reversible cerebral ischaemia in man:intraoperative monitoring of the somatosensory evoked response. Acta Neurochir Suppl (Wien) 42:3-7, 1988
PubMed
9) Friedman WA, Chadwick GM, Verhoven FJS, et al:Monitoring of somatosensory evoked potentials during surgery for middle cerebral artery aneurysms. Neurosurgery 29:83-88, 1991
 
10) Kidooka M, Nakasu Y, Watanabe K, et al:Monitoring of somatosensory-evoked potentials during aneurysm surgery. Surg Neurol 27:69-76, 1987
PubMed
11) Momma F, Wang AD, Symon L:Effects of temporary arterial occlusion on somatosensory evoked responses in aneurysm surgery. Surg Neurol 27:343-352, 1987
PubMed
12) Mizoi K, Yoshimoto T:Permissible temporary occlusion time in aneurysm surgery as evaluated by evoked potential monitoring. Neurosurgery 33:434-40, 1993
PubMed
13) 佐久間潤, 高萩周作, 板倉 毅ほか:後脛骨神経体性感覚誘発電位を用いた前大脳動脈瘤血流一時遮断時の術中モニタリング. 脳卒中の外科 22:355-361, 1994
 
14) Mizoi K, Yoshimoto T:Intraoperative monitoring of the somatosensory evoked potentials and cerebral blood flow during aneurysm surgery-safety evaluation for temporary vascular occlusion-. Neurol Med Chir (Tokyo) 31:318-325, 1991
PubMed
15) Little JR, Lesser RP, Luders H:Electrophysiological monitoring during basilar aneurysm operation. Neurosurgery 20:421-427, 1987
PubMed
16) Manninen PH, Patterson S, Lam AM, et al:Evoked potential monitoring during Posterior fossa aneurysm surgery:a comparison of two modalities. Can J Anaesth 41:92-97, 1994
PubMed
17) 川口哲郎, 藤田稠清, 細田弘吉ほか:Temporary clipping の安全性とその限界-direct cortical response (DCR) 測定による検討-. 脳卒中の外科 19:522, 1991
 
18) 児玉南海雄:内頚動脈瘤手術における運動誘発電位を用いた前脈絡叢動脈血流不全のモニタリング. 第31回日本脳卒中の外科学会, 2002
 
19) Siesjo BK:Pathophysiology and treatment of focal cerebral ischemia. Part II:Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992
PubMed
20) Tayler CL, Selman WR, Kiefer SP, et al:Temporary vessel occlusion during intracranial aneurysm repair. Neurosurgery 39:893-906, 1996
 
P.248 掲載の参考文献
1) Ujiie H, Tachibana H, Hiramatsu O, et al:Effects of size and shape (aspect ratio) on the hemodynamics of saccular aneurysms:A possible index for surgical treatment of intracranial aneurysms. Neurosurgery 45:119-130, 1999
PubMed
2) Ujiie H, Tamano Y, Sasaki K, et al:Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm? Neurosurgery 48:495-503, 2001
PubMed
3) Griffith TM:Modulation of blood flow and tissue perfusion by endothelium derived relaxing factor. Exp Physiol 79:873-913, 1994
PubMed
4) Masuda H, Zhuang YJ, Singh TM, et al:Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arterioscler Thromb Vasc Biol 19:2298-2307, 1999
 
5) Hashimoto N, Handa H, Hazama F:Experimentally induced cerebral aneurysms in rats. Surg Neurol 10:3-8, 1978
PubMed
6) Hashimoto N, Handa H, Nagata I, et al:Animal models of cerebral aneurysms:Pathology and pathogenesis of induced cerebral aneurysms in rats. Neurol Res 6:33-40, 1984
PubMed
7) Hashimoto N, Kim C, Kikuchi H, et al:Experimental induction of cerebral aneurysms in monkeys. J Neurosurg 67:903-905, 1987
PubMed
8) Kondo S, Hashimoto N, Kikuchi H, et al:Apotosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 29:182-189, 1998
 
9) Roach MR, Scott S, Ferguson GG:The hemodynamic importance of the geometry of bifurcation in the circle of Wilhs (glass model studies) . Stroke 3:255-267, 1972
PubMed
10) Simkins TE, Stebens WE:Vibrations recorded from the adventitial surface of experimental aneurysms and artriovenous fistulas. Vasc Surg 8:153-165, 1974
 
P.249 掲載の参考文献
11) Stehbens WE:Flow in glass models of arterial bifurcation and berry aneurysms at low Reynolds numbers. Q J Exp Physiol 60:181-192, 1975
PubMed
12) Steiger HJ, Poll A, Liepsch DW:Hemodynamic stress in terminal saccular arteurysms:laser-Doppler study. Heart Vessels 4:162-169, 1988
 
13) Zhuang YJ, Singh TM, Zarins CK, et al:Sequential increases and decreases in blood flow stimulates progressive intimal thickening. Eur J Endovasc Surg 16:301-310, 1998
 
14) Liepsch DW, Steiger HJ, Poll A:Hemodynamic stress in lateral saccular aneurysms. Bioeheology 24:689-710, 1987
PubMed
15) Ujjie H, Liepsch DW, Goetz M, et al:Hemodynamic study of the anterior communicating artery. Stroke 27:2086-2094, 1996
 
16) Fukuda S, Hashimoto N, Naritomi H, et al:Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 101:2532-2538, 2000
PubMed
17) 貝原 真:血管モデル系での血液凝固, 血栓形成機構の解析. 日本バイオレオロジー誌 9:165-171, 1995
 
18) Moncada S, Palmer RMJ, Higgs EA:Nitric oxide:physiology, pathology and pharmacology. Pharmacol Rev 43:109-142, 1991
 
19) Chyatte D, Bruno G, Desai S, et al:Inflammation and intracranial aneurysms. Neurosurgery 45:1137-1147, 1999
PubMed
20) Suzuki J, Ohara H:Clinicopathological study of cerebral aneurysms origin, rupture, repair and growth. J Neurosurg 48:505-514, 1978
PubMed
21) 玉野吉範, 氏家弘, 吉本成香ほか:中大脳動脈瘤を有する分岐部の流体力学的特長. 脳神経外科 29:921-930, 2001
 
22) Chang J, Roach MR:Hemodynamic method to predict whether Hunterian ligation of the basilar artery will lead to thrombosis of basilar bifurcation aneurysms. Neurosurgery 20:249-253, 1987
PubMed
23) Kamiyama H:Bypass with radial artery graft. No Shinkei Geka 22:911-924, 1994
PubMed
24) Steinberg GK, Drake CG, Peerless SJ:Deliberate basilar or vertebral artery occlusion in the treatment of intracranial aneurysms Immediate results and long-term outcome in 201 patients. J Neurosurg 79:161-173, 1993
PubMed
25) Steiger HJ:Pathophysiology of development and rupture of cerebral aneurysms. Acta Neurochir Suppl 48:1990
PubMed
26) 氏家 弘:脳動脈瘤と血流 日本バイオレオロジー誌 15:29-32, 2001
 
27) 氏家 弘, 吉本成香, 堀 智勝ほか:分岐部動脈瘤の流れの可視化. 脳卒中の外科 27:439-445, 1999
Medical*Online
P.254 掲載の参考文献
1) 種子田護, 山田和雄, 木下章ほか:未破裂脳動脈瘤は将来クモ膜下出血の原因となりうるのか? 脳卒中 14:768-772, 1992
 
2) Kataoka K, Taneda M, Asai T, et al:Structural fragility and in flammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 30:1396-1401, 1999
 
3) 片岡和夫, 山田恭史, 近藤澄夫ほか:破裂脳動脈瘤における瘤内血管内皮細胞の病態. 脳卒中の外科 24:23-26, 1996
 
4) Austin GM, Schievink W, Williams R:Controlled pressure-volume factors in the enlargement of intracranial aneurysms. Neurosurgery 24:722-730, 1989
PubMed
5) Kataoka K, Taneda M, Asai T, et al:Difference in nature of ruptured and unruptured cerebral aneurysms. Lancet 355:203, 2000
PubMed
6) Slosberg PS:Nonoperative management of ruptured intracranial aneurysms. Clin Neurosurg 21:90-99, 1974
PubMed
7) 山田恭史, 片岡和夫, 黒田良太郎ほか:未破裂内頸動脈瘤の病態. 特に動眼神経麻痺について. The Mt. Fuji Workshop on CVD 13:171-173, 1995
 
8) Meyer FB, Huston III J, Riederer SS:Pulsatile increases in aneurysm size determined by cine phase-contrast MR angiography. J Neurosurg 78:879-883, 1993
 
9) Wardlaw JM, Cannon J, Statham PE et al:Does the size of intracranial aneurysms change with intracranial pressure? Observations based on color "power" transcranial Doppler ultrasound. J Neurosurg 88:846-850, 1998
 
10) 伊藤守:泉佐野市民病院脳外科 ; 山田和雄:名屋市大脳神経外科.私信
 
11) Nawashiro H:Aneurysmal walls in unruptured intracranial aneurysms. Lancet 355:1368, 2000
PubMed
12) 谷口禎規, 佐藤進, 関口賢太郎ほか:山形市における破裂脳動脈瘤の発生率. 脳卒中 15:1-6, 1993
 
13) 大熊洋揮, 蛯名国彦, 鈴木重晴:青森県下北地区における破裂脳動脈瘤の発生状況. 地域基幹病院における患者登録による推定. 脳卒中 17:466 472, 1995
 
14) 大間々真一, 鈴木倫保, 久保直彦ほか:岩手県におけるくも膜下出血の発生状況. 昭和55年と平成4年の比較. 脳卒中 21:219-224, 1999
 
15) Inagawa T:Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke 32:1499-1507, 2001
PubMed
16) The International Study of Unruptured Intracranial Aneurysms Investigators.:Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 339:1725-1733, 1998
 
17) Berenstein A, Flamm ES, Kupersmith MJ, et al:Unruptured intracranial aneurysms. N Engl J Med 340:1439-1442, 1999
PubMed
18) Ausman JI:The New England Journal of Medicine report on unruptured intracranial aneurysms:a critique. Surg Neurol 51:227-229, 1999
PubMed
19) Kobayashi S, Orz Y, George B, et al:Treatment of unruptured cerebral aneurysms. Surg Neurol 51:355-362, 1999
PubMed
20) 片岡和夫:脳動脈瘤が破裂にいたるプロセスの解明. 日医雑誌 124:1395 1395, 2000
 
P.259 掲載の参考文献
1) Nishioka H:Report on the cooperative study of intracranial aneurysms and subarachoid hemorrhage. Section VII. 1. Evaluation of the conservative management of ruptured intracranial aneu-rysms, J Neurosurg 25:574-592, 1966
 
2) Swearingen B, Heros RC:Common carotid occlusion for unclippable carotid aneurysms:an old but still effective operation, Neurosurgery 21:288-295, 1987
PubMed
3) Barnett DW, Barrow DL, Joseph GJ:Combined extracranial-intracranial bypass and intraoperative balloon occlusion for the treatment of intracavemous and proximal carotid artery aneurysms, Neurosurgery 35:92-97, 1994
 
4) Barrow DL, Cargill J C. H.:Aneurysms of the intracavemous carotid artery, in G. T. Tindall, P R. Cooper and D. L. Barrow (eds):The Practice of Neurosurgery. Baltimore, Wilhams &Wilkins, 2013-2032, 1996
 
5) Bavinzski G, Killer M, Ferraz-Leite H, et al:Endovascular therapy of idiopathic cavemous aneurysms over 11 years, AJNR Am J Neuroradiol 19:559-565, 1998
 
6) Date I, Ohmoto T:Long-term outcome of surgical treatment of intracavemous giant aneurysms, Neurol Med Chir (Tokyo) 38 (Suppl):62-69, 1998
 
7) Drake CG, Peerless SJ, Ferguson GG:Hunterian proximal arterial occlusion for giant aneurysms of the carotid circulation, J Neurosurg 81:656-665, 1994
PubMed
8) Gelber BR, Sundt TJ:Treatment of intracavemous and giant carotid aneurysms by combined internal carotid ligation and extra-to intracranial bypass, J Neurosurg 52:1-10, 1980
 
9) Silvani V, Rainoldi F Gaetani P, et al:Combined STA/MCA arterial bypass and gradual internal carotid artery occlusion for treatment of intracavernous and giant carotid artery aneurysms, Acta Neurochir (Wien) 78:142-147, 1985
PubMed
10) Al-Rodhan NRF Piepgras DG, Sundt TMJ:Transitional cavervous aneurysms of the internal carotid artery., Neurosurgery 33:993-998, 1993
 
11) Horowitz M, Fichtel E Samson D, et al:Intracavernous carotid artery aneurysms:the possible importance of angiographic dural waisting. case report, Surg Neurol 46:549-552, 1996
 
12) Lee AG, Mawad ME, Baskin DS:Fatal subarachnoid hemorrhage from the rupture of a totally intracavemous carotid artery aneruysm:case report, Neurosurgery 38:596-599, 1996
 
13) Linskey ME, Sekhar LN, Hirsch WJ, et al:Aneurysms of the intracavernous carotid artery:clinical presentation, radiographic features, and pathogenesis, Neurosurgery 26:71-79, 1990
 
14) Linskey ME, Sekhar LN, Hirsch WJ, et al:Aneurysms of the intracavernous carotid artery:natural history and indications for treatment, Neurosurgery 26:933-937, 1990
 
15) Kupersmith MJ, Hurst R, Berenstein A, et al:The benign course of cavernous carotid artery aneurysms,J Neurosurg 77:690-693, 1992
PubMed
16) Date I, Asari S, Ohmoto T:Cerebral aneurysms causing visual symptoms:their features and surgical outcome, Clin Neurol Neurosurg 100:259-267, 1998
PubMed
17) Date I, kamitani M, Ohmoto T:Unilateral hypotonic seizures successfully diagnosed by ictal SPECT with technetium-99m-HMPAO in a patient with a brain tumour., J Neurol Neurosurg Psychiat 58:509-510, 1995
 
18) Tamaki N, Kim S, Ehara K, et al:Giant carotid-oph-thalmic artery aneurysms:direct clipping utilizing the"trapping-evacuation"technique, J Neurosurg 74:567-572, 1991
 
19) Lye RH, Jha AN:Unruptured aneurysms of the intracavemous internal carotid artery:outcome following carotid ligation or conservative treatment, Br J Neurosurg 3:181-188, 1989
PubMed
20) Kak VK, Taylor AR, Gordon DS:Proximal carotid ligation for internal carotid aneurysms. A long-term follow-up study, J Neurosurg 39:503-513, 1973
PubMed
21) Mount LA:Results of treatment of intracranial aneurysms using the Selverstone clamp, J Neurosurg 25:660-682, 1959
 
22) Giannotta SL, McGillicuddy JE, Kindt GW:Gradual carotid artery occlusion in the treatment of in-accessible internal carotid artery aneurysms, Neurosurgery 5:417-421, 1979
 
23) Odom GL, Tindall GT:Carotid ligation in the treatment of certain intracranial aneurysms, Clin Neurosurg 15:101-116, 1968
PubMed
24) Roski RA, Spetzler RF, Nulsen FE:Late complications of carotid ligation in the treatment of intracranial aneurysms, J Neurosurg 54:583-587, 1981
PubMed
25) Heros RC, Nelson PB, Ojemann RG, et al:Large and giant paraclinoid aneurysms:surgical techniques, complications, and results, Neurosurgery 12:153-163, 1983
PubMed
26) Houkin K, Kamiyama H, Kuroda S, et al:Long-term patency of radial artery graft bypass for reconstruction of the internal carotid artery, J Neurosurg 90:786-790, 1999
PubMed
P.265 掲載の参考文献
1) Batjer HH, Kopitnik TA, Giller CA, et al:Surgery for paraclinoid carotid artery aneurysms. J Neurosurg 80:650-658, 1994
PubMed
2) Day AL:Aneurysms of the ophthalmic segment. J Neurosurg 72:677-691, 1990
PubMed
3) Kobayashi S, Kyoshima K, Gibo H, et al:Carotid cave aneurysms of the internal carotid artery. J Neurosurg 70:216-221, 1989
PubMed
4) Nakagawa E Kobayashi S, Takemae T, et al:Aneurysms protruding from the dorsal wall of the internal carotid artery. J Neurosurg 65:303-308, 1986
 
5) Ogawa A, Suzuki M, Ogasawara K:Aneurysms at nonbranching sites in the supraclimoid portion of the internal carotid artery:Internal carotid artery trunk aneurysms. Neurosurgery 47:578-586, 2000
PubMed
6) Sugita K:Microneurosurgical Atlas, Springer, Berlin, p18-19, 1985
 
7) Yasargil MG, Fox JL:The microsurgical approach to intracranial aneurysms. Surg Neurol 3:7-14, 1975
PubMed
8) Fries G, Perneczky A, van Lindert E, et al:Contralateral and ipsilateral microsurgical approaches to carotid-opthalmic aneurysms. Neurosurgery 41:333-343, 1997
 
9) Kakizawa Y, Tanaka Y, Orz Y, et al:Parameters for contralateral approach to ophthalmic segment aneurysms of the internal carotid artery. Neurosurgery 47:1130-1137, 2000
PubMed
10) Kim JM, Romano A, Sanan A, et al:Microsurgical anatomic features and nomenclature of the paraclinoid region. Neurosurgery 46:670-682, 2000
PubMed
11) Nishio S, Matsushima T, Fukui M, et al:Microsurgical anatomy around the origin of the ophthalmic artery with reference to consralateral pterional surgical approach to the carotid-opthalmic aneurys. Acta Neurochir 76:82-89, 1985
 
12) Perneczky A, Knosp E, Vorkapic P et al:Direct surgical approach to Infraclinoidal aneurysms. Acta Neurochir 76:36-44, 1985
PubMed
13) Gibo H, Lenkey C, Rhoton AL Jr:Microsurgical anatomy of the supraclinoid portion of the internal carotid artery J Neurosurg 55:560-574, 1981
PubMed
14) Krisht AE Barrow DL, Barnett DW, et al:The microsurgical anatomy of the superior hypophyseal artery. Neurosurgery 35:899-903, 1994
 
15) Tanaka Y, Hongo K, Tada T, et al:Radiometric analysis of paraclinoid carotid aneurysms. J Neurosurg 96:649-653, 2002
PubMed
16) Oikawa S, Kyoshima K, Kobayashi S:Surgical anatomy of the juxtadural ring area. J Neurosurg 89:250-254, 1998
PubMed
17) Ito K, Kakizawa Y, Hongo K, et al:3-dimensional contrast medium enhanced computed tomographic cistemography for preoperative evaluation of surgical anatomy on intradural paraclinoid aneurysms of the internal carotid artery:Technical note. Neurosurgery, 2002 (in press)
 
18) Sheikh B, Ohata K, El-Naggar A, et al:Contralateral approach to carotid cave aneurysms. Acta Neurochir 142:33-37, 2000
PubMed
19) Hongo K, Watanabe N, Matsushima N, et al:contralateral pterional approach to a giant internal carotid-ophthalmic artery aneurysm:Technical case report. Neurosurgery 48:955-959, 2001
PubMed
P.269 掲載の参考文献
1) 大平貴之, 河瀬 斌:内視鏡外科UPDATE 脳神経外科領域での内視鏡外科, 神経内視鏡手術.医学のあゆみ 197 (5):431-434, 2001
 
2) 種子田護:脳動脈瘤最近の知見新しい治療法神経内視鏡支援手術.17 (6):684-686, 1999
 
3) 加藤庸子, 佐野公俊, 神野哲夫:脳動脈瘤手術への神経内視鏡の応用ポイント.脳神経外科ジャーナル 10 (4):279, 2001
 
4) Kato Y, Sano H, Nagahisa S, et al:Endoscope-Assisted Microsurgery for cerebral aneurysms, Minimally Invasive Neurosurgey, United States, 43:91-95, 2000
 
5) 嘉山孝正, 松森保彦, 毛利 渉ほか:内視鏡支援巨大脳動脈瘤の手術.日本脳神経外科学会抄録集 60:196, 2001
 
6) Tamaki N, Hara Y, Takaishi Y, et al:Angled rigid neuroendoscope for ontinuour intraoperative visual monitoring:technical note, Journal of clinical neuroscience, Scotoland, 8 (2):148-501, 2001
PubMed
7) Taniguchi M, Takimoto H, Yoshimine T, et al:Application of a rigid endoscope to the microsurgical management of 54 cerebral aneurysms:results in 48 patients, Journal of Neurosurgery, United States, 91 (2):231-237, 1999
 
8) 国広華奈, 嘉山孝正, 林真司ほか:Paraclinoid aneurysmにおける神経内視鏡の有用性.日本脳神経外科学会総会抄録集 60:196, 2001
 
9) 中瀬裕之, 上田勝弘, 榊寿右ほか:神経内視鏡支援Keyhole microsurgery.日本脳神経外科学会抄録集 59:321, 2000
 
10) Van Lindert E, Perneczky A, Fries G, et al:The supraorbital keyhole approach to supratentorial aneurysms:concept and technique, Surgical neurology, Germany, 49 (5):481-489, 1998
PubMed
P.276 掲載の参考文献
1) Vinuela E Duckwiler G, Mawad M:Guglielmi detachable coil embolization of acute intracranial aneurysm:perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 86:475-482, 1997
 
2) Serbinenko FA:Balloon catehterization and occlusion of major cerebral vessels. J Neurosurg 41:125-145, 1974
 
3) Guglielmi G, Vinuela F Sepetka I, et al:Electrothrombosis of saccular aneurysms via endovascular approach. Part 1:Electrochemical basis, technique, and experimental results. J Neurosurg 75:1-7, 1991
PubMed
4) Guglielmi G, Vinuela F Dion J, et al:Electrothrombosis of saccular aneurysms via endovascular approach Part 2:Preliminary clinical experience. J Neurosurg 75:8-14, 1991
PubMed
5) ボストンサイエンティフィック・ジャパン社内資料
 
6) 兵頭明夫, 根本繁 編:GDCを用いた脳動脈瘤血管内手術, 医学書院, 東京, 1999
 
7) Moret J, Cognard C, Weill A, et al:The Remodeling technique in the treatment of wide neck intracranial aneurysms:Angiographic and clinical follow up, about 56 cases. Interventional Neuroradiology 3:21-35, 1997
PubMed
8) Murayama Y, Vinuela F Tateshima S, et al:Cellular responses of bioabsorbable polymeric materialand Guglielmi Detachable Coil in experimental aneurysms. Stroke 33:1120-1128, 2002
 
P.281 掲載の参考文献
1) 塩川芳昭, 斉藤 勇:脳底動脈本幹部動脈瘤 (transpetrosal approachを中心に) II頭蓋底の解剖と手術 2. 錐体骨周辺部 5 脳動脈瘤の手術, 図説脳神経外科, 頭蓋底機能, 解剖, 手術 Medical view, 東京, pp90-97, 1997
 
2) Day JD, Giarnnotta, SL, Fukushima T:Extradural temporopolar approach to lesions of the upper basilar artery and infrachias-maticregion. J Neurosurg 81:230-235, 1994
 
3) Day JD, Fukushima T, Giannotta SL:Cranial base approaches to posterior circulation aneurysms. J Neurosurg 87:544-554, 1997
PubMed
4) Dolenc VV:A combined epi-and subdural direct approach to carotid-ophthalmic aneurysms. J Neurosurg 62:667-672,1985
PubMed
5) Hayakawa M, Murayama Y, Duckwiler GR, et al:Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system. J Neurosurg 93:561-8, 2000
PubMed
6) 塩川芳昭, 佐藤栄志, 小西善史, 斉藤 勇:脳底動脈動脈瘤に対する頭蓋底手術と血管内手術の選択:ビデオジャーナル vol 4, 3, 1996
 
7) Anson JA, Lawto MT, Spetzler RF:Characteristics and surgical treatment of dolichoectatic and fusiform aneurysms. J Neurosurg 84:185-193, 1996
 
8) Gupta S:To clip or to coil?Today patients with cerebral aneurysms face a difficult choice:brain surgery or a less proven alternative. Time Mar 4; 159 (9):78, 2002
 
9) Regli L, Uske A, de Tribolet N:Endovascular coil placement compared with surgical clipping for thetreatment of unruptured middle cerebral artery aneurysms:aconsecutive series. J Neurosurg 90:1025-30, 1999
 
10) McDougall CG, Halbach VV, Dowd CF et al:Endovascular treatment of basilar tip aneurysms using electrolytically detachable coils. J Neurosurg 84:393-399, 1996
PubMed
11) Raftopoulos C, Mathurin P, Boscherini D, et al:Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option. J Neurosurg 93:175-82, 2000
 
12) 斉藤 勇, 塩川芳昭, 小西善史:脳動脈瘤に対する血管内手術.臨床と研究 75:9:26-30, 1998
 
13) Lawton MT;Basilar apex aneurysms:Srugical results and perspectives from an initial experience. Neurosurg 50:1-10, 2002
 
14) Singh V, Gress DR, Higashida RT et al:The learning curve for coil embolization of unruptured intracranial aneurysms. AJNR 23:768-71, 2002
PubMed
15) Konishi Y, Sato E, Shiokawa Y, et al:A combined surgical and endovascular treatment for a case with five vertebro-basilar aneurysms and bilateral internal carotid artery occlusions. Surg Neurol 50:363-366, 1998
PubMed
16) Lawton MT, Daspit CP, Spetzler RF:Technical aspects and recent trends in the management of large and giant midbasilar artery aneurysms. Neurosurgery 41:513-521, 1997
PubMed

第7章 モヤモヤ病のトピックス

P.285 掲載の参考文献
1) Hosoda Y:Pathology of so-called"spontaneous occlusion of the circle of Willis" Pathol Annu 19 Pt 2:221-44, 1984
 
2) Hosoda Y, Ikeda E, Hirose S:Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease) . Clin Neurol Neurosurg 99 (Suppl 2):S203-8, 1997
 
3) Kono S, Oka K, Sueishi K:Histopathologic and morphometric studies of leptomeningeal vessels in moyamoya disease. Stroke 21 (7):1044-50, 1990
PubMed
4) Oka K, Yamashita M, Sadoshirna S, Tanaka K:Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol 392 (3):247-61, 1981
 
5) Soriano SG, Cowan DB, Proctor MR, et al:Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 50 (3):544-9, 2002
PubMed
6) Ross R, Glomset JA:The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295 (7):369-77, 1976
PubMed
7) Lindner V, Reidy MA:Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A 88 (9):3739-43, 1991
PubMed
8) Majesky MW, Lindner V, Twardzik DR, et al:Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 88 (3):904-10, 1991
PubMed
9) GA, Raines EW, Sprugel KH, et al:Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253 (5024):1129-32, 1991
 
10) Yoshimoto T, Houkin K, Takahashi A, et al:Angiogenic factors in moyamoya disease. Stroke 27 (12):2160-5, 1996
PubMed
11) Malek AM, Connors S, Robertson RL, et al:Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg 27 (4):182-9, 1997
PubMed
12) Yoshimoto T, Houkin K, Takahashi A, et al:Evaluation of cytokines in cerebrospinal fluid from patients with moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2):S218-20, 1997
 
13) Noda A, Suzuki Y, Takayasu M, et al:Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease. Acta Neurochir (Wien) 142 (11):1275-9, 2000
PubMed
14) Aoyagi M, Fukai N, Yamamoto M, et al:Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27 (10):1750-4, 1996
PubMed
15) Yamamoto M, Aoyagi M, Fukai N, et al:Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke 29 (6):1188-93, 1998
PubMed
16) Yamamoto M, Aoyagi M, Tajima S, et al:Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Stroke. 28 (9):1733-8, 1997
PubMed
17) Yamamoto M, Aoyagi M, Fukai N, et al:Increase in prostaglandin E(2) production by interleukin 1 beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res 85 (10):912-8, 1999
PubMed
18) Bonduel M, Hepner M, Sciuccati G, et al:Prothrombotic disorders in children with moyamoya syndrome. Stroke 32(8):1786-92, 2001
PubMed
19) Tsuda H, Hattori S, Tanabe S, et al:Screening for aetiology of thrombophilia:ahigh prevalence of protein S abnormality. Ann Clin Biochem 36 (Pt 4):423-32, 1999
 
20) Tsuda H, Hattori S, Tanabe S, et al:Thrombophilia found in patients with moyamoya disease. Clin Neurol Neurosurg. 99 Suppl 2:S229-33, 1997
 
21) Masuda J, Ogata J, Yutani C:Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24 (12):1960-7, 1993
 
22) Tanigawara T, Yamada H, Sakai N, et al:Studies on cytomegalovirus and Epstein-Barr Virus infection in moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2):S225-8, 1997
 
23) Yamada H, Deguchi K, Tanigawara T, et al:The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 99 Suppl 2:S221-4, 1997
 
24) 笠井直人, 藤原悟, 児玉南海雄ほか:Moyamoya病の原因に関する研究.脳神経外科 10 (3):251-61, 1982
 
25) Ikezaki K, Han DH, Kawano T, et al:A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 28 (12):2513-7, 1997
 
26) Wakai K, Tamakoshi A, Ikezaki K, et al:Epidemiological features of moyamoya disease in Japan:findings from a nationwide survey. Clin Neurol Neurosurg 99 (Suppl 2):S1-5, 1997
 
27) Ikezaki K, Loftus CM:Moyamoya Disease, American association of neurological surgeons, Rolling Meadows, 55-64, 2001
 
P.291 掲載の参考文献
1) Ikeda H, Sasaki T, Yoshimoto T, et al:Mapping of a familial moyamoya disease gene to chromosome 3p24. 2-p26. Am J Hum Genet. 64:533-537, 1999
PubMed
2) Inoue TK, Ikezaki K, , Sasazuki T, et al:Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15:2000
PubMed
3) Yamauchi T, Tada M, Houkin K, et al:Linkage of familial moyamoya disease to chromosome 17q25. Stroke, 2000
PubMed
4) Kong A, Cox NJ:Allele-sharing models:LOD scores and accurate linkage tests. Am J Hum Genet. 61:1179-88, 1997
PubMed
5) Kruglyyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis:A unified multipoint
 
6) 有波忠夫:ウイリス動脈輪閉塞症の病因遺伝子に関する研究.ウイリス動脈輪閉塞症の病因・病態に関する研究班, 平成14年度研究報告書, P49-50, 2002
 
7) Timmers C, Taniguchi T, Hejina J, et al:Positional cloning of a novel Fanconi anemia Gene, FANCD2. Molecular cell 7:241-248, 2001
 
8) Schalling M, Hudson TJ, Buetow KH, et al:Direct detection of novel expanded trinucleotide repeats in the human genome. Nature Genetics 4:135-139, 1993
PubMed
9) Guy CA, Bowen T, Jones I, et al:CTG18. 1 and ERDA-1 CAG/CTG repeat size in bipolar disorder. Neurobiology Disease 6:302-307, 1999 approach. Am. J. Hum. Genet. 58:1347-1363, 1996
 
10) Nakamoto M, Takebayashi H, Kawaguchi Y, et al:ACAG/CTG repeat expansion in the normal population. Nature Genetics 17:385-386, 1997
 
11) Lindblad K, Nylander PO, Zander C, et al:Two commonly expanded CAG/CTG repeat loci involvement in affecteve disorders?Mol. Psychatr. 3:405-410, 1998
 
12) Saccone, C:The evolution of mitochondrial DNA. Curr. Opin. Genet. Dev., 4:875-881, 1994
PubMed
13) Anderson, S., Bankier, A. T., et al:Sequence and organization of the human mitochondrial genome. Nature 290:457-465, 1981
PubMed
14) 池田秀敏, 吉本高志:モヤモヤ病と遺伝子-もやもや病の民族的偏在に関する分子生物学的検討-. 分子脳血管病 1:45-48, 2002
 
P.297 掲載の参考文献
1) 鈴木二郎, 高久 晃, 旭方旗ほか:日本人に多発する脳底部網状異常血管像を示す疾患群の検討.脳と神経 17:767-777, 1965
 
2) Suzuki J, Takaku A:Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in the base of brain. Arch Neurol 20:288-299, 1969
PubMed
3) Suzuki J, Kodama N:Moyamoya disease-a review. Stroke 14:104-109, 1983
PubMed
4) Hasuo, Mihara E Matsushima T:MRI and MR angiography in moyamoya disease. J Magn Reson Imaging 8:762-766, 1998
 
5) Houkin K, Aoki T, Takahashi A, et al:Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 25:2159-2164, 1994
PubMed
6) 宝金清博, 中山若樹, 黒田敏:MRAによる術後治療効果の判定.厚生科学研究費補助金特定疾患対策研究事業ウィリス動脈輪閉塞症の病因, 病態に関する研究.平成11年度報告書 29-36, 2000
 
7) 中山若樹, 宝金清博, 黒田敏:MRAによるもやもや病の病期分類.厚生科学研究費補助金特定疾患対策研究事業ウィリス動脈輪閉塞症の病因, 病態に関する研究.平成13年度報告書 45-48, 2002
 
8) 中山若樹, 宝金清博, 黒田敏:MRAによる術前後の病態評価.厚生科学研究費補助金特定疾患対策研究事業ウィリス動脈輪閉塞症の病因, 病態に関する研究.平成11-13年度報告書 25-30, 2002
 
9) Pereira PL, Farnsworth CT, Duda SH, et al:Pediatric moyamoya Syndrome:follow-up study with MR angiography. AJNR 167:526-528, 1996
 
10) 中山若樹, 宝金清博, 黒田敏:血行再建術による血行動態の経時的変化-MRAを用いた前向き調査による検討.厚生科学研究費補助金特定疾患対策研究事業ウィリス動脈輪閉塞症の病因, 病態に関する研究.平成12年度報告書 35-44, 2001
 
11) 中川原譲二:SPECTによるモヤモヤ病の病期 (重症度) 分類.厚生科学研究費補助金特定疾患対策研究事業ウィリス動脈輪閉塞症の病因, 病態に関する研究.平成11-13年度報告書59-63, 2002
 
P.302 掲載の参考文献
1) Karasawa J, Kikuchi H, Furuse S, et al:Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 49:679-88, 1978
PubMed
2) Ikezaki K, Matsushima T, Kuwabara Y, et al:Cerebral circulation and oxygen metabolism in childhood moyamoya Disease:a perioperative positron emission tomography study. J Neurosurg 81:843-50, 1994
PubMed
3) Touho H, Karasawa J, Ohnishi H:Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Stroke-moyamoya disease. Stroke 27:282-9, 1996
PubMed
4) Miyamoto S, Akiyama Y, Nagata I, et al:Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg focus 5:Article 5, 1998
PubMed
5) Kawaguchi S, Sakaki T, Kakizaki T, et al:Clinical features of the haemorrhage type moyamoya disease based on 31 cases. Acta Neurochir (Wien) 138:1200-10, 1996
PubMed
6) Yoshida Y, Yoshimoto T, Shirane R, et al:Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage:An extensive follow-Up study. Stroke3030:2272-6, 1999
PubMed
7) Karasawa J, Kikuchi H, Furuse S, et al:A surgical treatment of "moyamoya"disease""encephalo-myo synangiosis" Neurol Med Chir (Tokyo) 17:29-37, 1977
PubMed
8) Karasawa J, Touho H, Ohnishi H, et al:Cerebral revascularization using omental transplantation for childhood moyamoya disease. J Neurosurg 79:192-6, 1993
PubMed
9) Matsushima Y, Inaba Y:Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Childs Brain 11:155-170, 1984
PubMed
10) Matsushima T, Inoue T, Suzuki SO, et al:Surgical treatment of moyamoya disease in pediatric patients-comparison between the results of indirect and direct revascularization procedures. Neurosurgery 31:401-5, 1992
PubMed
11) Miyamoto S, Kikuchi H, Karasawa J, et al:Pitfalls in the surgical treatment of moyamoya disease. Operative tecniques for refractory cases. J Neurosurg 68:537-43, 1988
 
12) Touho H, Karasawa J, Ohnishi H, et al:Surgical reconstruction of failed indirect anastomosis in childhood Moyamoya Disease. Neurosurgery 32:935-40, 1993
PubMed
13) Miyamoto S, Nagata I, Morimoto M, et al:Fundamental techniques of vascular anastomosis. Jpn J Neurosurg 9:451-6, 2000
 
14) Yamada K, Miyamoto S, Nagata I, et al:Reverse steal phenomenon in moyamoya disease. Jpn J Neurosurg 4:145-150, 1995
 
15) Iwama T, Hashimoto N, Tsukahara T, et al:Perioperative complications in adult moyamoya disease. Acta Neurochir (Wien) ;132 (1-3):26-31, 1995
 
16) Karasawa J, Touho H, Ohnishi H, et al:Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 84:468-76, 1996
 
17) Miyamoto S, Kikuchi H,Karasawa J, et al:Study of the posterior circulation in moyamoya disease. Part 2:Visualdisturbances and surgical treatment. J Neurosurg 65:454-60, 1986
 
18) Miyamoto S, Kikuchi H, Karasawa J, et al:Study of adult cases of moyamoya disease. No To Shinkei 37:561-6, 1985
 
19) Akiyama Y:Training for microvascular anastomosis in rats. Jpn J Neurosurg 9:437-4, 2000
 
P.307 掲載の参考文献
1) 川口哲郎, 細田弘吉, 柴田裕次ほか:もやもや病に対するMultiple burr-hole operationの有用性と問題点について.脳卒中の外科 28:81-90, 2000
Medical*Online
2) Isono M, Ishii K, Kamida T, et al:Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr Neurosurg 36:14-21, 2002
PubMed
3) 今泉俊雄, 端 和夫, 中村 徹ほか:モヤモヤ病のSynangiosisに用いる各組織の血管新生能.脳外 17:515-520, 1989
 
4) Houkin K, Kuroda T, Ishikawa T, et al:Neovascularization (Angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya diease?Acta Neurochir (Wien) 142:269-276, 2000
 
5) 柏木史郎, 野村貞宏, 北原哲博ほか:もやもや病に対する外科的治療の改善点.脳卒中の外科 28:126-129, 2000
Medical*Online
6) 松島善治:モヤモヤ病に対する間接的血管吻合術. 脳外 26:769-785, 1998
 
7) Yoshimoto T, Houkin K, Takahashi A, et al:Angiogenic factors in moyamoya disease. Stroke 27:2160-2165, 1996
PubMed
8) Hojo A, Hoshimaru M, Miyamoto S, et al:Role of transforming growth factor-β1 in the pathogenesis of moyamoya disease. J Neurosurg 89:623-629, 1998
 
9) Karasawa J, Kikuchi H, Furuse S, et al:A surgical treatment of"moyamoya"disease, "encephalomyo synangiosis" Neurol Med Chir (Tokyo) 17:29-37, 1977
PubMed
10) Karasawa J, Touho H, Ohnishi H, et al:Cerebral revascularization using omental transplantation for chilhood moyamoya disease. J Neurosurg 79:192-196, 1993
 
11) 石井鐐二:モヤモヤ病に対する外科的治療.脳外 14:1059-1068, 1986
 
12) 河村 強, 今泉茂樹, 桜井芳明ほか:ウィリス動脈輪閉塞症に対する各種外科的治療の検討.脳外 22:933-938, 1994
 
13) Kinugasa K, Mandai S, Tokunaga K, et al:Ribbon encephalo-duro-arterio-myo-synangiosis for moyamoya disease. Surg Neurol 41:455-461, 1994
PubMed
14) Nakashima H, Meguro T, Kawada S, et al:Long-term results of surgically treated moyamoya disease. Clinical Neurology and Neurosurgery 99 (suppl. 2):S156-S161, 1997
 
15) 徳永浩司, 日下 昇, 河田幸波ほか:もやもや病に対する Ribbon encephalo-duro-arterio-myo-synangiosis (Ribbon EDAMS) 施行例における術前・術後の脳循環動態の検討.脳卒中の外科 28:91-97, 2000
Medical*Online
16) 竹内茂和, 阿部博史, 小澤常徳ほか:もやもや病に対する encephalo-galeo-synangiosisの効果.脳卒中の外科 28:98-103, 2000
Medical*Online
17) 松島善治, 青柳 傑, 成相 直ほか:小児もやもや病患者のWechsler知能テストによる長期知能予後.II. Encephalo-duro-arterio-synangiosis施行後10年以上経過した患者の検討.小児の脳神経 21:232-238, 1996
 
18) 松島善治:もやもや病に対する間接的血管吻合術におけるfacts and myths-revisit-.脳卒中の外科 28:104-110, 2000
Medical*Online
19) Matsushima T, Inoue T, Suzuki SO, et al:Surgical treatment of moyamoya disease in pediatric patients - Comparison between the results of indirect and direct revascularization procedures. Neurosurgery 31:401-405, 1992
PubMed
20) 細井和貴, 唐澤 淳, 瀧本洋司ほか:EDAS非有効例もやもや病に対する直接的血行再建術の検討. 脳外誌 10:718-725, 2001
 

第8章 診断 治療装置と機材の進歩

P.312 掲載の参考文献
1) 山田圭介, 宮本享, 橋本信夫ほか:脳底動脈先端部未破裂脳動脈瘤の治療, 脳卒中の外科 (in press)
 
P.318 掲載の参考文献
1) Leksell L:The stereotaxic method and radiosurgery of the brain. Act Chir Scand 102:316, 1951
 
2) 社会保険研究所:放射線治療, 医科点数表の解釈, 社会保険研究所, 東京, p524-528, 2002
 
3) 井上武宏, 井上俊彦:定位放射線治療の的確な診断と治療.定位放射線治療の機器の種類と使用方法.脳神経外科ジャーナル 11:2002 (掲載予定)
 

第9章 治療薬開発に関する最新情報

P.331 掲載の参考文献
1) Barinaga M:Finding new drugs to treat stroke. Science 272:664, 1996
PubMed
2) Astrup J, et al:Thresholds in cerebral ischemia-The ischemic penumbra. Stroke 12:723, 1981
PubMed
3) 脳血管障害急性期に対するAVSの有用性.臨床と研究 66 (11):217, 1989
 
4) Ogawa A, et al:Ebselen in acute middle cerebral altery occlusion:a placebo-controlled, doubleblind clinical trial. Cerebrovasc. Dis., 112, 1999
PubMed
5) Tateishi N, et al:Astrocytic activation and delayed infarctd expansion after permanent focal ischemia in rats. Part II:Suppression of astrocytic activation by a novel agent (R)-(一)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infact expansion and early improvement of neurologic edficits. J. Cereb. Blood Flow Metab. 22:723-734, 2002
 
6) Yamaguchi T, et al:Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-272, 1993
 
7) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Group:Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
PubMed
P.334 掲載の参考文献
1) Yamaguchi T, et al:Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-272, 1993
 
2) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group:Tissue plasminogen activator for acute Ischemic stroke. N Engl J Med 333:1581-1587, 1995
 
3) Hacke, et al:Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Aute Stroke Study (ECASS) . JAMA 274:1017-1025, 1995
 
4) Hackem, et al:Randomized double-blinde placebo-controlled trial of thrombolytic therapy with Intravenous alteplase in acute ischemic stroke (ECASS-II) . Lancet 352:1245-1251, 1998
 
5) Clarke WM, et al:Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset. The ATLANTIS Study:A Randomized Controlled Trial JAMA 282:2019-2026, 1999
 
6) Multicenter Acute Stroke Trial-ltaly (MAST-1) Group:Randomized controlled trial of streptokinase, aspirin, and combination of both In treatment of acute Ischemic stroke. Lancet 346:1509-1514, 1995
 
7) Hommel M, et al:Multicentre Acute Stroke Trial Europe:Thrombolytic stroke. N Engl J Med 335:145-150, 1996
 
8) Donnan GA, et al:Streptokinase for acute Ischemic stroke with relation to time of administratin. JAMA 276:961-966, 1996
 
9) Furlan A, et al:Intra-arterial prourokinase for acute Ischemic stroke. The PROACT II study:a randomized controlled trial. JAMA 282:2003-2011, 1999
PubMed
10) Atarashi J, Ohtomo E, Araki G, et al:Clinical utility of urokinase in the treatment of acute stage cerebral thrombosis:Multi-center double blind study in comparison with placebo (Translated from Japanese) . Clin Eval 13:659-709, 1985
 
11) Hand P, et al:The third International Stroke Trial (IST-3) . Stroke 31:2866, 2000
 
12) International Stroke Trial Collaboration Group:The International Stroke Trial (IST):a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute Ischemic stroke. Lancet 349:1569-1581, 1997
 
13) CAST (Chinese Acute Stroke Trial) Collaboration Group:Randomized placebo-controlled trial of early aspirin use In 20000 patients with acute Ischemic stroke. Lancet 349:1641-1649, 1997
 
14) The abciximab in Ischemic stroke Investigators:Abciximab In acute Ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 31:601-609, 2000
PubMed
15) Adams H, Hacke W, for AbESTT Investigators:Abciximab In emergent stroke treatment trial (AbESTT) . Stroke 31:2864-2865, 2000
 
16) CAPRIE Steering Committee:A randomized, blinded, trial of clopidogrel versus aspirin In patients at risk of Ischemic events (CAPRIE) . Lancet 348:1329-1339, 1996
 
17) Bertrand ME, et al:Double-blind study of the safety of clopidogrel with and without a loading dose In combination with aspinn after coronary stenting:The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) . Cirulation 102:624-629, 2000
 
18) Goto F et al:Cilostazol Stroke Prevention Study:a placebo-controlled double-blind trial for secondary prevention of cerebral Infarction. J Stroke Cerebrovasc Dis 9:147-157, 2000
 
P.339 掲載の参考文献
1) Furberg C, Psaty B, Meyer J:Circulation 92:1326, 1995
PubMed
2) Ad Hoc Subcommittee of the Liaison Committee of the WHO and the International Society of Hypertension.
 
3) Kario K, Shimada K, Schwartz JE, et al:J Am Coll Cardiol 38:238-245, 2001
PubMed
4) Blood Pressure Lowering Treatment Trials's Collaboration. Lancet 359:1955, 2000
 
5) Stier Jr. CT, Benter IE Ahmad S, et al:Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13:115-121, 1989
 
6) Fujii K, Weno BL, Baumbach GL, et al:Effects of antihypertensive treatment on focal cerebral infarction. Hypertension 19:713-716, 1992
 
7) Hirawa N, Uehara Y, Kawabata Y, et al:Long-term inhibition of renin-angiotensin system sustains memory function in aged dahl rats. Hypertension 34:496-502, 1999
PubMed
8) Kawakami N, Yainashita T, Nakano S, et al:Effect of angiotensin converting chronic ischemic patients. 166:93-95, 1996
 
9) PROGRESS Collaborative enzylne inhibitor on Acta Neurol Scand Group:Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 358:1033-1041, 2001
PubMed
10) Nishimura Y, Ito T, Saavedra JM:Angiotensin II ATl blockade normalizes cerebrovasucular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31:2478-2486, 2000
 
11) Blezer ELA, Nicolay Klaas, Koomans HA, et al:Losartart versus enalapril on cerebral edema and proteiluria in stroke-prone hypertensive rats. Am J Hypertens 14:54-61, 2001
 
12) Dai WJ, Funk A, Herdegen T, et al:Blockade of central angiotensin ATl receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30:2391-2399, 1999.
 
13) Lindholm LH, Ibsen H, Dahlof Bjron, et al:Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For End-point reduction in hypertension study (LIFE):a randomized trial against atenolol. Lancet 359:1004-1010, 2002
 
14) Collins R, Peto R, MacMahon S, et al:Blod pressure, stroke, and coronary heart disease Lancet 335:827-838, 1990
 
15) Campese VM, Lasseter KC, Ferrario CM, et al:Omapatrilat versus lisinopril:efficacy and neurohonmonal profile in salt-sensitive hypertensive patients Hypertension 38:1342-1348, 2001
PubMed
16) Wenzel RR, Spieker L, Qui S, et al:I1-Imidazoline agonist moxonidine decrease sympathetic nerve activity and blood pressure in hypertensives. Hypertension 32:1022-1027, 1998
PubMed
P.349 掲載の参考文献
1) Stamler J, Wentworth D, Neaton JD:Is relationship between senum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) . JAMA 256 (20):2823-2828, 1986
 
2) Shepherd J, Cobbe SM, Ford I, et al:Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 (20):1301-1307, 1995
 
3) Scandinavian Simvastatin Survival Study Group:Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease:Scandinavian Simvastatin Survival Study (4S) . Lancet 344:1383-1389, 1994
 
4) 日本動脈硬化学会診療・疫学委員会:動脈硬化性疾患診療ガイドライン2002版 http://jas.umin.ac.jp/
 
5) Endo A:The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 33 (11):1569-1582, 1992
PubMed
6) Lennemas H, Fager G:Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmaconet 32:403-425, 1997
 
7) Mabuchi H, Sakai T, Sakai Y, et al:Reduction of serum cholesterol in heterozygous patients with familial hypecholesterolemia. Additive effects of compactin and cholestyramine. N Engl J Med 308:609-613, 1983
 
8) Nawrocki JW, Weiss SR, Davidson MH, et al:Reduction of LDL cholesterol by 25%to 60%in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 15 (5):678-682, 1995
PubMed
9) 東方利徳, 馬渕 宏:臨床成人病 31 (11):1542-1545, 2001
 
10) Kajinami K, Koizumi J, Ueda K, et al:Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Hokuriku NK-104 Study Group. Am J Cardiol 85 (2):178-183, 2000
 
11) Noji Y, Higashikata T, Inazu A, et al:Long-t not equalerm treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia. Atherosclerosis 163 (1):157-164, 2002
 
12) Olsson AG, Pears J, McKellar J, et al:Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol 88 (5):504-508, 2001
PubMed
13) Davidson M, Ma P, Stein EA, et al:Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or Ilb hypercholesterolemia. Am J Cardiol 89 (3):268-275, 2002
PubMed
14) Prospective studies collaboration:Cholesterol, diastolic blood pressure, and stroke:13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346:1647-1653, 1995
PubMed
15) Iso H, Jacobs DR Jr, Wentworth D, et al:Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial N Engl J Med 320 (14):904-910, 1989
 
16) Benfante R, Yano K, Hwang U, et al:Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 25 (4):814-820, 1994
 
17) Bucher HC, Griffith LE, Guyatt GH:Effect of HMG-CoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intem Med 128 (2):89-95, 1998
 
18) Crouse JR 3rd, Byington RP, Hoen HM, et al:Reductase inhibitor monotherapy and stroke prevention. Arch Intem Med 157 (12):1305-1310, 1997
 
19) Blauw GJ, Lagaay AM, Smelt AH, et al:Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28 (5):946-950, 1997
PubMed
20) Sacks FM, Pfeffer MA, Moye LA, et al:The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (14):1001-1009, 1996
 
21) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339 (19):1349-1357, 1998
 
22) Smilde TJ, van Wissen S, Wollersheim H, et al:Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP):aprospective, randomised, double-blind trial. Lancet 357 (9256):577-581, 2001
 
23) Schwartz GG, Olsson AG, Ezekowitz MD, et al:Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:arandomized controlled trial. JAMA 285 (13):1711-1718, 2001
 
24) Rubins HB, Robins SJ, Collins D, et al:Gemfibrozil for the secondary prevention of coronaryheart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341 (6):410-418, 1999
 
25) Bloomfield Rubins H, Davenport J, Babikian V, et al:Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol:The Veterans Affairs HDL Intervention Trial (VA-HIT) . Circulation 103 (23):2828-2833, 2001
PubMed
26) Downs JR, Clearfield M, Weis S, et al:Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (20):1615-1622, 1998
PubMed
27) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals:arandomised placebo-controlled trial. Lancet 360:7-22, 2002
PubMed
28) Fuster V, Badimon L, Badimon JJ, et al:The pathogenesis of coronary artery disease and the acute coronary syndromes (1) . N Engl J Med 326 (4):242-250, 1992
PubMed
29) Fuster V, Badimon L, Badimon JJ, et al:The pathogenesis of coronary artery disease and the acute coronary syndromes (2) . N Engl J Med 326 (5):310-318, 1992
PubMed
30) Libby P Molecular bases of the acute coronary syndromes. Circulation 91 (11):2844-2850, 1995
PubMed
31) Plehn JE Davis BR, Sacks FM, et al:Reduction of stroke incidence after myocardial infarction with pravastatin:the Cholesterol and Recurrent Events (CARE) study. Circulation 99 (2):216-23, 1999
 

第10章 各種製品の臨床評価

P.354 掲載の参考文献
1) 白土博樹, 井須豊彦, 清水幸彦, 西岡 健, 野中 雅, 阿部 悟, 松村茂樹, 清水 匡, 市村 亘, 鈴木恵士郎, 南部敏和:リニアック脳定位照射法の Prospective Dose-Escalation Study. 脳神経外科 21 (12):1089-1095, 1993
 
2) Aoyama H, Shirato H, Nishioka T, Kagei K, Onimaru R, Suzuki K, Ushikoshi S, Houkin K, Kuroda S, Abe H, Miyasaka K:Treatment outcome of single or hypofractionated single-isocentric stereotactic irradiation (STI) using a linear accelerator for intracranial arteriovenous malformation. Radiother Oncol. 59 (3):323-8, 2001
PubMed
3) Shirato, H., Takamura, A., Tomita, M., Suzuki, K., Nishioka, T., Isu, T., Kato, T., Sawamura, Y, Miyamachi, K, Abe, H., Miyasaka, K.:Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 37:385-391, 1997
PubMed
4) Kagei K, Shirato H, Suzuki I et al:Small-field fractionated radiotherapy with or without stereotactic boost for vestibular schwamoma. Radiother Oncol. 59:341-347, 1999
 
5) 定位放射線照射のための線量標準測定法-STIの線量とQA-, 日本医学物理学会編, 通商産業研究社, 2001
 

技術資料編

P.359 掲載の参考文献
1) M. Collice, et al:Multidiscuplinary (surgical and endovascular) approach to intracranialaneurysms:Journal of Neurosurgical Sciences, Vol.42, Suppl. 1 to No.1, 1998
 
2) Yuichi Murayama, et al:Bioabsorbable polymeric material coils for embohzation of intracranial aneurysms:apreliminary experimental study:J Neurosurg 94:・454-463, 2001
 
P.367 掲載の参考文献
1) A. C. Frakar and A. W Ruff:J. Met 29:22, 1977
 
2) K. Ram:Failure of a Heifetz aneurysm clip. J. Neurosurg 57:233-239, 1982
 
3) 早川 勲, 土田富穂:動脈瘤クリップの折損に関する金属学的研究.脳神経外科誌 10 (2):135-140, 1982
 
4) M. Dujovny:Aneurysm Clip Motion during Magnetic Resonance Imaging:In Vivo Experimental study with Metallurgical Factor Analysis. Neursurgery 17:543-548, 1985
 
5) New, E J, Paul. M. D, et al:Potential Hazards and Artifacts of Ferromagnetic and Nonferro-magnetic Surgical and Dental Matarials and Devices in Nuclear Magnetic Resonance Imagng. Radiolofy April, 139-148, 1983
 
6) T. Nagatani:Titanium aneurysm clips:Mechanical characteristics and clinical trial Neurol Med Chir Suppl (Tokyo) 38:39-44, 1998
 
7) 阿部栄二, 奥山幸一郎, 石川英次郎ほか:MRI における生体金属のアーチファクト.臨床整形外科 20 (12):1347-1353, 1995
 
8) B. Romner. MR imagng and aneurysm clips. J. Neurosurg 70:426-431, 1989
 
9) ASTM Meeting (Phoenix. November 94) Symposium on Medical Applications of Titanium and Its Alloys.
 
10) ANNUAL BOOK OF ASTM STANDARDS 2001 SECTION 13 Medical Devives and Services
 
P.382 掲載の参考文献
1) 渡辺俊明, 幸 敏志, 斎藤健一, 佐藤聖子, 杉本次郎, 大堀祐司:新規脳保護薬MCI-186 の薬理学的検討.薬理と治療 25 (Sup7):s1691-s1698, 1997
 
2) Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K:Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Redox Report 2 (6):333-338, 1996
 
3) 内藤裕二, 吉川敏一, 近藤元治:消化管における虚血-再灌流障害.J. Act. Oxyg. Free Rad. 1 (3):315-327, 1990
 
4) Watanabe T, Nishi H, Morita I, Murota S:Preventive effect of MCI-186 on 15-HPETE-induced vascular endothelial cell iiljury in vitro. Prostaglandins. Leukoc. Essent. Fatty Acids 33 (1):81-87, 1998
 
5) Watanabe T and Egawa M:Effect of an antis-troke agent MCI-186 on cerebral arachidonate cascade. J. Pharmacol. Exp. Ther. 271 (3):1624-1629, 1994
 
6) 渡邉和俊, 渡辺一彦, 早瀬哲郎:MCI-186のラジカル消去機構の検討.薬理と治療 25 (Sup 7):s1699-s1707, 1997
 
7) Watanabe K, Watanabe K, Kuwahara T, Yamamoto Y Free radical-induced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) . J. Jpn. Oil. Chem. Soc. 46 (7):797-801, 1997
 
8) Ono S, Okazaki K, Sakurai M, Inoue Y Density functional study of the radical reactions of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186):implication for the biological function of MCI-186 as a highly potent antioxidative radical scavenger. J. Phys. Chem. A. 101 (20):3769-3775, 1997
 
9) Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito KI:Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281 (2):921-927, 1997
 
10) Floyd RA, Watson JJ, Wong PK:Sensitive assay of hydroxy radical formation utilizing high pressure liquid chromatography with electro-chemical detection phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods 10 (3-4):221-235, 1984
 
11) Mizuno A, Umemura K, Nakashima M:Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen. Pharmacol. 30 (4):575-578, 1998
PubMed
12) Abe K, YUki S, Kogure K:Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (4):480-485, 1988
 
13) Yamamoto T. YUki S, Watanabe T, Mitsuka M, Saito KI, Kogure K:Delayed neuronal death prevented by inhibition of increarsed hydroxyl radical formation in a transient cerebral ischemia. Brain Res. 762 (1-2):240-242, 1997
 
14) 渡辺俊明ほか:脳保護薬エダラボンの薬理作用.臨床と薬物治療 21 (7):686-692, 2002
 
15) 浅野孝雄:脳虚血とフリーラジカル.血管医学 3 (3):255-262, 2002
Medical*Online
16) 浅野孝雄:フリーラジカルからみた脳保護薬. 医薬ジャーナル社刊, 大友英一編著, 脳梗塞急性期治療の進歩-エダラボンの臨床-:pp24-35, 2002
 
17) 渡邉庸子, 渡辺俊明, 安東賢太郎, 幸敏志, 斎藤健一, 石橋明:ラジカル消去薬3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) と脳卒中急性期治療薬の相互作用の検討.薬理と治療 25 (Sup 7):s1709-s 1718, 1997
 
18) 柴田久雄, 新井重紀, 井澤美苗, 村崎光邦, 高松康雄, 井澤修, 高橋千寿子, 田中正彦:MCI-186 (Edaeavone) の第一相臨床試験-単回および反復投与試験における安全性と薬物動態の検討-.臨床薬理 29 (6):863-876, 1998
 
19) 横田慎一, 熊谷雄治, 内海光朝, 井澤志名野, 村崎光邦, 秋元啓, 岩本正人, 湯浅隆行, 岩野政雄:脳血管障害治療薬MCI-186の高齢者における薬物動態.臨床薬理 28 (3):693-702, 1997
 
20) 高松康雄, 渡辺俊明:イヌにおける3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) の脳脊髄液中濃度に関する研究.薬理と治療 25 (Sup 7):s1793-s 1797, 1997
 
21) Houkin K, et al:Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction:Clinical evaluation using magnetic resonance imaging and spectros-copy. Journal of Stroke and Cerebrovascular Disease 7:315-322, 1998
 
22) 三森研自ほか:急性期脳梗塞患者の局所脳血流量に及ぼすMCI-186の効果-シングルフォトン断層法 (SPECT) による検討-. Thera-peutic Research 19:1333-1345, 1998
 
23) Otomo E, et al:Clinical Effects of Edaravone (MCI-186), a Novel Free Radical Scavenger, on Acute Brain Infarction. Randomized, Placebo-Controlled, Double-blind Study at Multicenters. Submitted.
 
24) 三菱ウェルファーマ社内集計
 
25) 豊田一則:脳梗塞-急性期における治療-. MEDICAMENT NEWS 1736, 2002
Medical*Online
26) 北川泰久ほか:心原性脳塞栓症に対するエダラボンの臨床経験.医薬ジャーナル社刊, 大友英一編著, 脳梗塞急性期治療の進歩-エダラボンの臨床-:pp88-91, 2002
 
27) 鈴木義広, ほか:急性期脳梗塞に対するエダラボンの有効性-従来の治療法との比較-.診断と治療90 (4):645-649, 2002
 
28) 高橋一夫, 小林祥泰:脳塞栓症における重症度別エダラボンの臨床効果.医薬ジャーナル社刊, 大友英一編著, 脳梗塞急性期治療の進歩-エダラボンの臨床-:pp 139-142, 2002
 
29) 吉岡亮, ほか:当科におけるエダラボンの使用経験, 医薬ジャーナル社刊, 大友英一編著, 脳梗塞急性期治療の進歩-エダラボンの臨床-:pp110-112, 2002
 
30) 山田圭一:脳血栓症に対するエダラボンの効果.医薬ジャーナル社刊, 大友英一編著, 脳梗塞急性期治療の進歩-エダラボンの臨床-:pp 106-109, 2002
 
31) 川上正人ほか:脳梗塞急性期例に対するエダラボンの効果.医薬ジャーナル社刊, 大友英一編著, 脳梗塞急性期治療の進歩-エダラボンの臨床-:pp101. 105, 2002
 
P.388 掲載の参考文献
1) Sudo T, Tachibana K, Toga K, et al:Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochem Pharmacol 59:347-356, 2000
PubMed
2) Umekawa H, Tanaka T, Kimura Y, et al:Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography Biochem Pharmacol 33:3339-3344, 1984
PubMed
3) Kimura Y, Tani T, Kanbe T, Watanabe K,:Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneim-Forsch. /Drug Res 35:1144-1149, 1985
 
4) Kawamura K, Watanabe K, Kimura Y,:Effect of cilostazol, a new antithrombotic drug, on cerebral circulation. Arzneim-Forsch. /Drug Res 35:1149-1154, 1985
 
5) Shintani S, Watanabe K, Kawamura K, et al:General Pharrnacological properties of cilostazol, a new antithrombotic drug. Arzneim-Forsch/Drug Res 35:1163-1172, 1985
 
6) Takahashi S, Oida K, FW iwara R, et al:Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 20:900-906, 1992
 
7) Ikeda Y, Kikuchi M, Murakami H, et al:Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo:randomized, double-blind cross-over study. Arzneim-Forsch. /Drug Res 37:563-566, 1987
 
8) Minami N, Suzuki Y, Yairtamoto M, et al:Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo. Life Sci 61:PI・383-389, 1997
 
9) 永川祐三, 小貫陽子, 折茂 肇ほか:シロスタゾール (OPC-13013) のアラキドン酸代謝に及ぼす影響.薬理と治療 14:6319. 6324, 1986
 
10) Uehara S, Hirayama A,:Effects of cilostazol on platelet function. Arzneim-Forsch. /Drug Res 39:1531-1534, 1989
 
11) 中村和男, 仮屋薗博子, 新川輝俊ほか:シロスタゾールの抗血小板作用と顆粒内容物放出抑制作用について.Jpn J Clin Pharmacol Ther 31 (1):53-54, 2000
 
12) Inoue T, Sohma R, Morooka S,:Cilostazol inhibit the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro. Thromb Res 93:137-143, 1999
PubMed
13) Nomura S, Shouzu A, Omoto S, et al:Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost 80:388-392, 1998
PubMed
14) Kawamura K, Fujita S, Tani T, et al:Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency. Arzneim.-Forsch. /Drug Res 35:1154-1156, 1985
 
15) Ishizaka N, Taguchi J, Kimura Y, et al:Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery. Atherosclerosis 142:41-46, 1999
PubMed
16) Inoue Y, Tbga K, Sudo T, et al:Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model. Br J Pharmacol 130:231-241, 2000
 
17) Tsuchikane E, Fukuhara A, Kobayashi T, et al:Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation 100:21-26, 1999
PubMed
18) Tsuchikane E, Katoh O, Sumitsuji, S, et al:Im-pact of cilostazol on intimal proliferation after directional coronary atherectomy Am Heart J 135:495-502, 1998
 
19) Sekiya M, Funada J, Watanabe K, et al:Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis. Arn J Cardiol 82:144-147, 1998
 
20) Elam MB, Heckman J, Crouse JR, et al:Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arterioscler. Thromb Vasc Biol 18:1942-1947, 1998
PubMed
21) Tani T, Uehara K, Sudo T, et al:Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats. Atherosclerosis 152:299-305, 2000
PubMed
22) Morishita R, Higashi J, Hayasahi S, et al:Role of hepatocyte growth factor in endothelial regulation:prevention of high D-glucose-in-duced endothelial cell death by prostaglandines and phosphodiesterase type 3 inhibitor. Diabetologia 40:1053-1061, 1997
 
23) Aoki M, Morishita R, Hayashi S, et al:Inhibition of neointimal forrnation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model. Diabetologia 44:1034-1042, 2001
PubMed
24) Otsuki M, Saito H, Xu X, et al:Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-κBbinding to its recognition sequence. Atherosclerosis 158:121-128, 2001
 
25) Nakamura T, Houchi H, Minami A, et al:Endothelium-dependent relaxation by cilostazol, a phosphodiesterase III inhibitor, on rat thoracic aorta. Life Sci 69:1709-1715, 2001
PubMed
26) 三島好雄, 勝村達喜, 内田發三ほか:慢性動脈閉塞症に対するOPC-13013の薬効評価-チクロピジンを対照薬とする二重盲検比較試験.医学のあゆみ 139:133-157, 1986
Medical*Online
27) Dawson DL, Cutler BS, Meissner MH, Strandness DE,:Cilostazol has beneficial effects in treatment of intermittent claudication. Results from a multicenter, randomized, prospective, double-blind trial. Circulation 98:678-686, 1998
PubMed
28) Beebe HG, Dawson DL, Cutler BS, et al:Anew pharmacological treatment for intermittent claudication:results of a randomized, multicenter trial. Arch Intren Med 159:2041-2050, 1999
 
29) Money S, Herd A, Isaacsohn JL, et al:Effect of cilostazol on walking distances in patients with interrnittent claudication caused by peripheral vascular disease. J Vasc Surg 27-267-275, 1998.
 
30) Dawson DL, Cutler BS, Hiatt WR, et al:A comparison of cilostazol and pentoxifilline for treating intermittent claudication. Am J Med 109:523-530, 2000
 
31) TASC working group.:Management of peripheral arterial disease. J Vasc Surg 31:S93, 2000
 
32) Gotoh E Tohgi H, Hirai S, et al:Cilostazol Stroke Prevention Study-aplacebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc 9:147-157, 2000
 
33) Kozuma K, Hara K, Yamasaki M, et al:Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation. Am Heart J 141:124-130, 2001
PubMed
34) Ikeda Y, Sudo T, Kimura Y,:In:Michelson A. D., editor. Platelets. San Diego:Academic Press. 817-823, 2002
 
P.393 掲載の参考文献
1) Granstrom E, Kindahl H, Samuelsson B:A method for measuring the unstable thromboxane A2:radioimmunoassay of the derived mono-O-methyl-thromboxane B2. Prostaglandins 12:929, 1976
PubMed
2) Hamberg M, Svensson J, Samuelsson B:Thromboxane:A new group of biologically active compounds derived from prostaglandin endoperoxydes. Proc Nat Acad Sci USA 72:2994, 1975
 
3) Moncada S, et al:An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable subsutance that inhibits platelet agrgregation. Nature 263:663, 1976
 
4) Vane JR:Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231:232, 1971
PubMed
5) Smith JB, Willis M:Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol 231:235, 1971
 
6) 大杉繁昭:実験的脳血管攣縮におけるThrom-boxane A, 合成酵素阻害剤の効果.日本外科宝函 55:297, 1986
 
7) 佐野圭司ほか:脳動脈瘤破裂後の脳血管攣縮 ならびに遅発性神経脱落症状に対するthrom-boxane合成酵素阻害薬OKY-046・Naの有用 性.医学のあゆみ 138:455, 1986
 
8) 小原克之ほか:選択的thromboxane合成酵素 阻害剤 (OKY-046) の実験的脳虚血急性期の血小板血栓形成, および血管口径に及ぼす影響. 脈管学 28:447, 1988
 
9) 大森啓造ほか:脳卒中患者における血漿 thromboxaneb, 濃度について.脳卒中 3:63, 1981
 
10) Astrup J, Siesjo BK, Symon L:Thresholds in cerebral ischemia:The ischemic penumbra. Stroke 7:135, 1981
 
11) 大友英一ほか:脳血栓症急性期におけるOKY-046の臨床的有用性.臨床医薬 7:353, 1991
Medical*Online

書評

最近チェックした商品履歴

Loading...